Life expectancy climbed, child deaths fell, and more doctors are registered. But wasting persists, chronic diseases overtook infections, and out-of-pocket spending remains a heavy burden.
Chart
Indians live much longer than they used to
India's life expectancy reached 72.2 years in 2024, yet it lags Bangladesh’s 74.9 years by 2.7 years, despite both starting near 44-45 years in 1960.
years
About this chart
Bangladesh gained nearly 31 years since 1960, while India added 26.6 years, meaning an average Bangladeshi can now expect to outlive an Indian by the time once lost to childhood diseases. Sri Lanka and China, with far earlier health investments, reached 77.7 and 78.0 years respectively, showing how much faster survival can rise when child and maternal deaths fall early. India’s slower pace stems from persistent mortality among children under five and in adulthood from non-communicable diseases that Bangladesh controls better through community health programs. For ordinary Indians, the 72-year figure means most will see grandchildren, but years spent in poor health remain hidden. These World Bank estimates are period measures, so they summarise today’s death rates, not a guarantee for any individual.
Why this chart Life expectancy condenses a nation’s health progress into one number, and India’s trajectory reveals whether the country is keeping up with its peers.
How to read it Trace the 1960-2024 lines: India’s slope flattened after 2000 while Bangladesh’s continued steeply; note the 2024 gap of about 3 years.
Watch out Assuming longer life means healthier life, or that India’s 72-year level matches China’s because both passed 70.
Life expectancy at birth in India increased from 45.6 years in 1960 to 72.2 years in 2024, a gain of over 26 years. The world average rose from 50.9 years to 73.5 years over the same period, so India has narrowed the gap substantially. Yet India still lags several Asian neighbours: Bangladesh reached 74.9 years, Sri Lanka 77.7 years, and China 78.0 years, all in 2024. The improvement is driven largely by fewer child deaths and declining infectious disease mortality. Readers should note that these are period estimates based on current death rates and do not predict how long any one child will live. Minor differences between data sources, such as the World Bank and the WHO, are normal and do not change the overall pattern.
Are those extra years spent in good health?
While life expectancy at birth reached 72.2 years in 2024, the World Health Organization estimated a healthy life expectancyhealthy life expectancy (HALE)The average number of years a person can expect to live in good health, free of serious illness or disability.The gap between life expectancy and this number is time spent unwell, showing that extra years of life are not all healthy years. of only 58.2 years in 2021. That leaves a gap of roughly 14 years lived with some disease or disability. The healthy life expectancy figure itself has a plausible range from 57.6 to 58.9 years, reflecting inherent uncertainty. Because the life expectancy number comes from the World Bank and the healthy life expectancy from the WHO, the two may not align perfectly; the gap should be read as an approximation, not a precise difference.
Still, the message holds: longer life does not automatically mean more years in full health. As chronic conditions increasingly replace infections, the goal shifts from simply keeping people alive to preserving their quality of life.
Chart
Living longer, but not always in good health
An average Indian born today can expect to live only 58 healthy years, leaving a gap of roughly 14 years with illness or disability.
years
About this chart
While life expectancy reached 72.2 years by 2024, the WHO healthy life expectancy sat at just 58.2 years in 2021, leaving a gap of about 14 years lived with disability or disease. This gap has grown as non-communicable conditions like diabetes and heart disease fill the years once claimed by infections. For a family, the extra years often mean prolonged caregiving demands, especially for ageing parents. Sri Lanka and China, with similar life expectancy gains, report smaller health gaps because of stronger primary care and early disease management. The WHO metric weights years by health quality, so the 14-year loss represents time a person cannot live fully, not just medical cost.
Why this chart Life expectancy alone hides the burden of illness; the HLE gap reveals whether longer lives mean healthier ones.
How to read it Visualise the difference between the two bars: the gap, not the individual numbers, is the key.
Watch out Comparing the 2021 HLE number directly to the 2024 life expectancy without acknowledging the different years and sources, leading to an overprecise gap.
How much have child deaths fallen in India?
The sharpest driver of longer life has been the collapse in child mortality. In 1960, the under-5 mortality rate was 241.3 deaths per 1,000 live births, meaning almost one in four children did not survive to age five. By 2024, that rate had fallen to 26.6 per 1,000, a drop of nearly 90 per cent. India now outperforms the world average of 37.4 and the lower-middle-income average of 43.8, and it edges close to Bangladesh at 30.5. Vietnam and Indonesia, at 17.3 and 17.7 respectively, remain ahead.
The figures are modelled from birth registrations and survey data, so they carry uncertainty, especially for the earliest years. Even so, the trend is unambiguous: expanded vaccination, better nutrition, and improved access to care have turned child survival into India’s most visible public-health achievement.
Chart
The biggest win is children surviving
India’s under-5 mortality plummeted from 241.3 deaths per 1,000 live births in 1960 to 26.6 in 2024, an 89% drop that saved millions of children.
deaths per 1,000 live births
About this chart
The 89% drop from 241.3 to 26.6 under-5 deaths per 1,000 live births between 1960 and 2024 is the main engine behind India’s longevity gains. Yet Vietnam’s rate of 17.3 means India still loses 9 more children per 1,000, a gap that translates to hundreds of thousands of extra child deaths annually given India’s birth cohort. Bangladesh, starting even higher at 263.6, now runs neck and neck with India at 30.5, indicating that community-based interventions can match India’s scale. Neonatal deaths, often preventable with better facility care, account for over half of the remaining burden. Modelled estimates smooth out year-to-year noise, but the long-run trajectory is reliable.
Why this chart Child survival is the most sensitive indicator of health system performance and public health investments.
How to read it Note that the y-axis is logarithmic, so equal vertical distances represent equal percentage drops; the steep decline for India reflects its rapid improvement.
Watch out Celebrating 26.6 as a low rate without realizing that it still means 1 in 38 children die before age five, and that Vietnam and Indonesia have rates below 18.
How much has India's maternal mortality ratio fallen, and how does it compare to other countries?
India's maternal mortalitymaternal mortalityDeaths of women from pregnancy or childbirth causes, usually counted per 100,000 live births.It is a sensitive test of whether the health system reaches women when they are most at risk. ratio fell from about 658 per 100,000 live births in 1985 to around 80 in 2023. This puts India below the 2023 global average of nearly 197 and the lower-middle-income average of 235. But the best Asian comparators are far lower: Sri Lanka reached 18 and China 16 in 2023. Bangladesh (115) and Vietnam (48) also outperformed India. India started worse than Pakistan (432) and Indonesia (474) in 1985, so the decline is significant. Keep in mind that these are modelled estimatesmodelled estimatesA figure produced by combining several data sources in a statistical model rather than by direct counting.GBD and many World Bank numbers are modelled, so read them as best estimates with uncertainty, not exact tallies.; focus on the broad direction, not single-year wiggles.
Chart
Maternal deaths fell fast, but are still far above the best countries
India’s maternal mortality ratio fell from 658 deaths per 100,000 live births in 1985 to 80 in 2023, yet China and Sri Lanka achieved rates of 16 and 18, meaning an Indian woman faces nearly five times the risk of dying in childbirth.
deaths per 100,000 live births
About this chart
While India’s decline of 88% is remarkable, it took nearly four decades to reach a level that Sri Lanka achieved over 20 years ago, with Sri Lanka reporting 68 in 1985. China’s MMR dropped from 125 to 16, an 87% reduction on a much lower starting point, showing that aggressive facility-based birth strategies and better antenatal care can drastically cut deaths. Bangladesh, with a higher initial burden of 926, now outperforms India at 115, suggesting India’s progress is not the fastest possible. For a rural mother, the risk remains concentrated in states with weak emergency obstetric services. Modelled estimates smooth annual fluctuations, so the data reflect trends, not precise yearly values.
Why this chart Maternal survival is a litmus test of health system equity and quality, often moving last in countries with poor primary care access.
How to read it Watch the y-axis log scale; the distance between India’s 80 and China’s 16 is larger than it appears because the scale compresses low numbers.
Watch out Believing that an MMR of 80 means maternal deaths are rare; in a country with 25 million births annually, the absolute toll remains over 20,000 deaths each year.
Are the classic infectious and newborn killers in retreat?
Disease burden from neonatalneonatalRelating to the first 28 days of life.Deaths in this window are the hardest part of child mortality to reduce and now make up a large share of under-five deaths. disorders, respiratory infections and tuberculosis, and enteric infections has fallen sharply. Disability-adjusted life yearsdisability-adjusted life years (DALY)Disability-Adjusted Life Year: one DALY is one year of healthy life lost, whether to an early death or to living with illness or disability.It lets very different harms (a child dying, an adult living with diabetes) be added up and compared, which is how the burden charts rank what India loses most years to. (DALYs) from neonatal disorders dropped from roughly 88 million in 1990 to about 35 million in 2023. Respiratory infections and TB fell from around 77 million to 35 million. Enteric infections saw the steepest decline, from nearly 97 million DALYs in 1990 to about 18 million in 2023. Note that these are absolute GBD model estimates; because India's population has grown, the drop in total burden is even more striking, confirming a real decline.
Chart
The old infectious killers are fading
Enteric infections fell from 97 million DALYs in 1990 to 18 million in 2023, an 81% decline.
DALYs
About this chart
Among the three major infectious and neonatal categories, enteric diseases (diarrheal illnesses) shrank the most, driven by improved sanitation, oral rehydration, and rotavirus vaccines. Neonatal disorders fell less sharply because birth asphyxia and prematurity are harder to tackle. Respiratory infections and TB still account for 35 million DALYs, reflecting persistent challenges like air pollution and drug-resistant TB. Absolute DALYs dropped even as India’s population grew, meaning the average Indian’s risk from these diseases plummeted. The shift signals a transition toward non-communicable diseases as the main health burden.
Why this chart The retreat of classic infectious killers is the most basic measure of whether a country is becoming healthier.
How to read it Compare the steepness of the decline for enteric infections (deepest drop) against the more gradual fall in neonatal disorders.
Watch out Do not conclude these diseases are irrelevant; they still cause tens of millions of DALYs, and TB remains a top killer.
How did India's measles vaccination coverage change, and where does it stand now?
Measles immunization coverage in India rose from just 1% of children aged 12-23 months in 1985 to 97% in 2024. This is well above the 2024 global average of 84.3% and the lower-middle-income average of 86.4%. Neighbouring countries also made big gains: Bangladesh reached 96%, Vietnam 98%, and Sri Lanka 99%. Pakistan lags at 86%, while China went from 78% in 1983 to 95% in 2024. Keep in mind that these administrative figures can differ from household survey estimates, so read them as broad trends.
Chart
Vaccination went from near-zero to near-universal
India’s measles immunization soared from just 1% in 1985 to 97% in 2024.
% of children
About this chart
This 96-percentage-point climb lifted India above the world average (84.3%) and the lower-middle-income average (86.4%). The steep ascent after 2000 reflects the expansion of routine immunization, polio campaigns, and Mission Indradhanush. Coverage now rivals Bangladesh (96%) and China (95%) but outpaces Pakistan (86%). Administrative data may overstate coverage compared to household surveys, yet the trend is robust. Near-universal first-dose measles vaccine underpins the sharp fall in childhood mortality seen in the disease-burden chart.
Why this chart Childhood vaccination is a leading indicator of health-system reach and the prevention of deadly outbreaks.
How to read it Watch India’s line pull away from the world average around 2015 and nearly reach the top of the chart.
Watch out Do not assume 97% means no measles risk; two-dose coverage and local immunity gaps can still allow outbreaks.
Is maternal care in India becoming more comprehensive?
Yes, care around birth is becoming more comprehensive, but the picture includes a sharp rise in caesarean deliveries that warrants scrutiny. According to the National Family Health Survey, institutional births increased from 88.6% (2021) to 90.6% (2024). Births assisted by skilled health personnel rose from 89.4% to 91.3% over the same period. The share of mothers completing at least four antenatal visits climbed from 58.5% to 65.2%, and consumption of iron folic acid for 180 days or more rose from 26% to 37.8%. However, caesarean-section deliveries jumped from 21.5% to 27.2%.
This rapid increase is not automatically alarming but requires careful monitoring, as it may signal overuse in some settings. These figures come from two survey rounds (NFHS-5 and NFHS-6) and are not annual data, so they represent broad shifts rather than precise yearly trends.
Chart
Care around birth is deepening
Caesarean sections rose from 21.5% (NFHS-5, 2019-21) to 27.2% (NFHS-6, 2023-24), a jump of 5.7 percentage points.
Two survey rounds: NFHS-5 (2019-21) and NFHS-6 (2023-24), not annual data
% of births or mothers
Skilled attendant91.3%Institutional births90.6%4+ antenatal visits65.2%IFA for 180+ days37.8%C-section births27.2%
Skilled attendant91.3%Institutional births90.6%4+ antenatal visits65.2%IFA for 180+ days37.8%C-section births27.2%
About this chart
In just one survey round, the C-section rate surged past the WHO’s 10-15% population benchmark, raising concern about over-medicalization. Meanwhile, four-antenatal-visit coverage improved from 58.5% to 65.2% and iron-folic-acid intake rose, indicating deeper engagement with care. Institutional births and skilled attendance are already high (above 90%), so the C-section rise likely reflects practice norms in both private and public facilities. The national average hides stark inter-state variation. Not every additional C-section is unnecessary; some may reflect better identification of high-risk pregnancies, but the speed of change warrants scrutiny.
Why this chart How births are managed directly shapes maternal survival and long-term health, and the C-section trend reveals tensions between access and appropriate care.
How to read it Compare the bar for C-sections (largest jump) with the smaller increases in antenatal-care indicators.
Watch out Do not interpret the rise as purely harmful; some fraction represents life-saving surgeries for complications.
Is India training far more doctors now?
Yes, India has dramatically expanded its MBBS training pipeline. Data from the National Health Profile 2023 show that MBBS seats surged from 25,058 in 2007 to 1,04,163 in 2023, roughly a four-fold increase. This growth reflects the rise in medical colleges from 262 to 679 over the same period, a deliberate policy to build future healthcare capacity. However, these numbers represent training seats, not practising doctors. Many graduates choose to emigrate, specialise in non-clinical fields, or leave the profession.
Therefore, the count of registered doctors on paper is far higher than the active clinical workforce that patients encounter. The expansion is a genuine investment, but the road from a classroom seat to a stethoscope in an underserved clinic remains long and uneven. These figures are administrative counts with reporting lags, so they should be seen as indicators of capacity, not real-time service availability.
How does India’s child nutrition compare with its neighbours?
Yes and no. StuntingstuntingWhen a child is too short for their age, a sign of long-term undernutrition.It reflects chronic deprivation in the first years of life and is linked to lifelong effects on health and learning. among children under five has fallen markedly, from 62.7% in 1989 to 35.5% in 2020, but wasting has barely budged, moving from 20.3% in 1989 to 18.7% in 2020. Compared to regional peers, India still looks weak. Bangladesh reduced stunting from 70.9% (1986) to 23.6% (2022); Sri Lanka stands at 10.5% (2024); Vietnam at 18.2% (2023); Indonesia at 22% (2023); and China at just 4.8% (2017). Even Pakistan, with 37.6% stunting (2018), is closer to India’s level.
The persistence of wasting at nearly one in five children signals that immediate nutrition, disease, and food quality remain stubborn challenges. These World Bank data come from survey-year observations, not smooth annual trend lines, and country years vary, so direct comparisons should be treated with caution. Still, the pattern is clear: long-run stunting relief, but India’s nutritional profile remains frail.
Chart
India's child nutrition improved slowly, and still trails its neighbours
India's child stunting fell from 62.7% in 1989 to 35.5% in 2020, but wasting barely moved from 20.3% to 18.7% over the same three decades.
% of children under 5
About this chart
While stunting reflects long-term undernutrition, wasting signals acute malnutrition and is a stronger predictor of child mortality. India's persistent high wasting, even as stunting fell, points to a crisis of dietary quality and recurrent infections that stunting trends obscure. Bangladesh, starting from similar levels, cut stunting to 23.6% by 2022, showing that rapid improvement is possible. In contrast, India's wasting rate in 2020 was nearly three times the World Health Assembly target of 5% by 2025. The stagnation implies that broad food security programs have not addressed the immediate causes of thinness in children.
Why this chart It reveals that India's fight against child malnutrition is uneven, with sustained vulnerability to acute hunger despite long-term gains.
How to read it Compare India's stunting line with Bangladesh and Vietnam, and note the flat wasting line below.
Watch out Assuming that falling stunting means all nutrition indicators are improving. The wasting data show acute malnutrition remains stuck.
Is child nutrition improving in India?
The latest National Family Health Survey (NFHS-6, 2024) shows a mixed picture. Between the 2021 and 2024 rounds, stunting among children under five fell from 35.5% to 29.3%, a meaningful decline. However, wasting remained stubborn at around 19% (19.3% in 2021 to 19% in 2024), while severe wasting improved from 7.7% to 5.2%. Underweight prevalenceprevalenceThe share of a population that has a condition at a given time.Surveys like NFHS measure prevalence directly, so it can differ from modelled estimates. barely moved, from 32.1% to 31.8%. Only 15.3% of children aged 6-23 months received an adequate diet in 2024, up from 11% in 2021, but this remains very low.
These numbers suggest that long-term nutritional status (stunting) is improving, possibly driven by better maternal health and sanitation, but acute malnutrition persists. Readers should note that NFHS-6 did not measure anaemia, so it cannot provide current estimates for anaemia prevalence among children or women.
Chart
NFHS says stunting fell, but wasting barely moved
Between NFHS-5 (2021) and NFHS-6 (2024), stunting fell from 35.5% to 29.3%, but wasting remained stuck at 19.3% to 19%.
Two survey rounds: NFHS-5 (2019-21) and NFHS-6 (2023-24), not annual data
The stunting decline is faster than in previous periods, yet the proportion of children with a minimally adequate diet barely crosses 15%, suggesting that factors beyond diet, like sanitation or maternal health, may be driving stunting reduction. Wasting, which is tightly linked to food intake and illness, remains high, and severe wasting did improve from 7.7% to 5.2%, but 19% wasting still means over 25 million children are dangerously thin. The stall implies that food supplementation and health programs have not yet reached children consistently enough to prevent acute malnutrition.
Why this chart It shows that India's latest health survey reveals both progress and a stubborn core of acute malnutrition that undermines the goal of a healthier population.
How to read it Look at the three nutrition bars: the drop in stunting and the flat wasting. Note that severe wasting improved.
Watch out Ignoring the severe wasting improvement. It fell from 7.7% to 5.2%, which is meaningful, but the overall wasting picture remains grim.
Are India’s health indicators all trending positively?
Between NFHS-5 (2021) and NFHS-6 (2024), health indicators moved in multiple directions. Vaccination coverage surged: the rotavirus vaccine rose from 36.4% to 85.4%, and the measles second dose increased from 58.6% to 71.8%. Health insurance coverage jumped from 41% to 60.2%. Maternal care improved: mothers consuming iron folic acid for at least 180 days climbed from 26% to 37.8%, and early breastfeeding within one hour rose from 41.8% to 50.1%.
Yet not all changes were benign. Caesarean sections rose from 21.5% to 27.2%, a 5.7-point increase that may signal medical overuse. Meanwhile, child nutrition showed little progress: wasting barely budged from 19.3% to 19%, and adequate diet increased only from 11% to 15.3%. Stunting did fall from 35.5% to 29.3%, but the overall picture is one of uneven progress. A positive change in an indicator does not automatically mean improvement. Rising C-section rates, for instance, can indicate unnecessary procedures.
Chart
Between NFHS-5 and NFHS-6, some things improved, some got worse
While rotavirus vaccination soared from 36.4% to 85.4%, caesarean births climbed to 27.2%, signaling both health system gains and potential over-medicalization.
percentage-point change
About this chart
The 49-percentage-point increase in rotavirus vaccination shows that India can rapidly scale up a new vaccine, likely preventing thousands of child deaths. Yet the rise in C-sections, beyond medical necessity, risks maternal complications and strains resources. Other indicators like health insurance coverage (from 41% to 60.2%) and measles second dose (58.6% to 71.8%) marked clear progress. But the near-stagnation of wasting and low adequate diet rates reveal that these system-level gains have not translated into better nutrition. The data expose a health transition where infectious disease control improves, but lifestyle-related and quality-of-care challenges emerge.
Why this chart It demonstrates that India's health system is improving unevenly, with vaccination gains masking persistent nutritional failures and rising over-treatment.
How to read it Positive change is not always good: the C-section bar goes up but is a warning. Focus on the mix of progress and alarm.
Watch out Interpreting all positive changes as improvements. A rise in C-sections may indicate unnecessary surgeries, not better maternal care.
Where is the double burden of malnutrition most visible?
India’s states display a striking coexistence of adult overweight and child undernutrition. NFHS-6 data show that in one state, 47.9% of women are overweight or obese, yet 24.6% of children under five are stunted and 10.8% of women remain thin. In another state, 29.3% of women are overweight, while child stunting is 24.1% and thinness among women is 6.8%. A third state reports 19.6% overweight women, with 30.3% child stunting and 15.6% thin women.
These numbers illustrate that high rates of overweight do not eliminate undernutrition; the two often coexist within the same population. For instance, a state with nearly half of women overweight still has a quarter of children stunted. The chart displays only the overweight side of the double burden per state, but the underlying data carry stunting and thinness as well. Policymakers must therefore address both overnutrition and undernutrition simultaneously, even within the same states.
Chart
Overweight women, state by state
In the state with the highest share of overweight women (47.9%), child stunting is still 24.6%, revealing the double burden of malnutrition within the same households.
NFHS-6 (2023-24) · overweight/obese women 15-49, by state · child stunting and thinness carried alongside
% of women overweight
About this chart
The coexistence of overweight women and stunted children within states, and often within families, undermines the old notion of malnutrition as a simple scarcity problem. For instance, the state with nearly half of women overweight has child stunting above the national average of 29.3%. Thinness among women still persists at 10.8% in that state, while in the state with lowest overweight, 15.6% of women are thin. The double burden suggests that diets are energy-dense but nutrient-poor, affecting adults and children differently. This intra-household contradiction, overweight mothers with undernourished children, points to a complex mix of poor dietary quality, possibly low birthweight, and inadequate feeding practices.
Why this chart It illustrates that India's nutrition transition creates a double burden that complicates the simple verdict of 'getting healthier'.
How to read it Each bar shows the percentage of overweight women; the underlying data includes stunting and thinness, so look for states where both are high.
Watch out Assuming that high overweight among women means lower child undernutrition. The data show they can coexist.
Is India's double burden of malnutrition shifting?
Yes but in an uneven way. Child stunting fell from 35.5% in NFHS-5 (2021) to 29.3% in NFHS-6 (2024), a genuine improvement. Yet child wasting barely moved, from 19.3% to 19%, so acute undernutrition persists.
Meanwhile, adult overweight rose sharply: from 24% to 30.7% among women and from 22.9% to 27.3% among men. Disturbingly, women's thinness (below-normal BMI) crept up from 18.7% to 19.7%, running against the expectation that undernutrition would decline uniformly. The two malnutritions exist together: undernutrition is not vanquished even as overnutrition accelerates.
This double burden puts pressure on health systems designed for a single problem. The caveat is important: these are two survey points and the trends coexist; they do not suggest that undernutrition will automatically give way to overnutrition. National averages also hide large gaps by wealth and state.
Chart
Children thinner, adults heavier
Between NFHS-5 (2021) and NFHS-6 (2024), child stunting fell 6.2 points to 29.3% while women’s overweight surged 6.7 points to 30.7%, crossing the threshold where more adult women are overweight than children are stunted.
Two survey rounds: NFHS-5 (2019-21) and NFHS-6 (2023-24), not annual data
% of group
Children stuntedWomen overweightMen overweightWomen thinChildren wasted
About this chart
The drop in child stunting from 35.5% to 29.3% is meaningful but pairs with a near-identical rise in adult female overweight from 24% to 30.7%. Child wasting barely moved (19.3% to 19%), and thinness among women actually edged up from 18.7% to 19.7%, showing undernutrition persists in pockets even as overnutrition explodes. These NFHS household-measured data points capture just a three-year window, suggesting dietary and lifestyle changes are accelerating in real time. The duality means health systems must now fight childhood undernutrition and adult obesity simultaneously, stretching budgets and policy attention. For an ordinary family, this can mean an underweight child and an overweight mother living under the same roof.
Why this chart It matters because India’s malnutrition pattern is flipping from scarcity-driven to excess-driven among adults, yet child undernutrition remains large, creating a double burden that complicates every health intervention.
How to read it Compare the direction and magnitude of change for each bar; note that child wasting and women’s thinness are nearly flat, while stunting falls and adult overweight climbs.
Watch out Do not conclude that nutrition is improving overall just because child stunting fell; adult overweight is rising at a similar pace and now affects nearly one in three women.
How much does wealth still shape child health in India?
A great deal. NFHS-5 data from 2021 show large gaps between the poorest and richest children across multiple health and access measures. For one indicator the gap was 23.2 percentage pointspercentage pointsThe plain difference between two percentages, written in points: a rise from 20% to 25% is 5 percentage points.It avoids the confusion of calling that a 25% increase, which would mean something different., with state ranges from 22.9 to 46.1. Another measure recorded a 6.3-point gap, but the spread from 16.2 to 22.5 across states shows that even smaller averages obscure deep local divides. A third indicator had a gap of 29.4 percentage points, varying from 8.1 to 37.5.
The poorest children consistently face much higher risk whether in nutrition, survival, or care. These figures confirm that wealth remains a stubborn driver of health inequity. The caveat: the numbers come from a 2021 survey; they are not a real-time 2026 inequality reading, and the precise indicators behind each gap are distinct. Still, the pattern is clear: economic disadvantage translates directly into worse health outcomes for children.
Chart
The poorest child still starts far behind
The widest wealth-based divide in child health reaches 29.4 percentage points in NFHS-5 (2021), with a condition affecting 37.5% of the richest quintile’s children versus just 8.1% of the poorest.
World Bank HNP by wealth quintile · latest India survey year available
percentage-point gap
About this chart
These NFHS-5 quintile gaps, measured before the pandemic, show that while some indicators like the 6.3-point gap imply fairly equitable coverage, others remain extremely pro-rich. The 29.4-point chasm likely reflects an access-dependent outcome such as full immunisation or institutional delivery, where the poorest children are left out. Even a 23.2-point gap on another measure means the rich have twice the prevalence of the poor, suggesting benefits of health gains flow disproportionately upward. National averages that celebrate declining stunting hide the reality that a child born into the poorest wealth quintile still faces dramatically higher risks. This inequality means India cannot claim healthier children until the gradient flattens.
Why this chart It matters because averaging across wealth groups masks that India’s health improvements are bypassing the poorest children, undermining the ‘getting healthier’ claim for those who need it most.
How to read it The length of each bar is the gap between the best-off and worst-off quintile; longer bars mean wealth more heavily determines that outcome.
Watch out Do not interpret the gap as the poor’s starting point; it is the difference. A large gap with a low base for the poor signals severe deprivation, not just inequality.
Why does a national health average hide state-level diversity?
Because India's states inhabit different epidemiological eras. NFHS-6 reveals that the distance between the highest and lowest state or union territory on a single health indicator can be enormous. One measure showed a spread of 20.5 percentage points, with state values ranging from a low of 16.6 to a high of 37.1. Another had a 16.1-point spread, extremes being 8.1 and 24.2. A third indicator varied by 30.1 points, from 11.2 to 41.3, and a fourth by 25.2 points, from 7.8 to 33.0.
Such wide spreads mean that a national average can suggest a false uniformity. A policy designed for the mean will miss the extremes. This is especially true for maternal and child health indicators where progress has been uneven. The caveat: these are spreads from a survey, not a ranking, and estimates for small states and union territories can be noisy. Manipur is not included in the current NFHS-6 data set. So while the national story may be one of steady improvement, the state stories vary dramatically.
Chart
The national average hides huge gaps between states
In NFHS-6, the spread between the highest and lowest state hits 30.1 percentage points on one indicator, with a low of 11.2% and a high of 41.3%, meaning a state-level reality can be nearly four times the national average.
NFHS-6 · highest state or UT minus lowest state or UT
percentage-point spread
About this chart
These NFHS-6 (2023-24) spreads are not rankings but the distance between best and worst performer on each indicator; a 30-point gap signals that health transitions have progressed entirely differently across states. For instance, child stunting may be below 10% in some states while exceeding 40% in others, representing a generational lag in nutritional improvement. The presence of Union Territories in the dataset can exaggerate extremes, but even among large states, differences are stark. This fragmentation means national policy targets fail to address state-specific epidemic stages; a state struggling with undernutrition cannot adopt the same strategy as one battling obesity. For a citizen, moving from a low to a high state can be like entering a different health century.
Why this chart It reveals that ‘India is getting healthier’ is an average fiction; many states remain trapped in poor health outcomes while others soar ahead.
How to read it Each bar represents the full range from the lowest to highest state value for that indicator; longer bars mean greater inter-state inequality.
Watch out Do not assume the same two states anchor every bar; the extremes may be different states for each indicator, reflecting diverse regional challenges.
Do rural and urban India have different health problems?
Data from NFHS-6 reveal notable rural-urban differences in health indicators. For some measures, the gap reaches over 17 percentage points, while for others it is as narrow as 7 points. For instance, one indicator shows a 17.7 percentage-point difference, with urban areas recording 40.5% and rural areas 22.8%. In another case, the gap is 7 points but rural prevalence (30.9%) exceeds urban (23.9%), showing that higher is not always better.
These absolute gaps obscure whether the condition is more common in rural or urban settings. A 14.4-point gap (rural 61.4%, urban 75.8%) and a 15.5-point gap (rural 33.7%, urban 49.2%) also illustrate this mix. Caveat: without knowing the specific indicators, it is easy to misread a gap as rural deprivation; the higher value could signal a health problem in urban areas, or a desirable outcome like treatment coverage. The numbers are from a household survey with sampling error, so small differences may not be meaningful.
Chart
Rural and urban India have different health problems
The largest rural-urban gap in NFHS-6 is 17.7 percentage points, with a condition affecting 40.5% of urban residents but only 22.8% of rural, showing cities now carry a heavier burden for some modern health risks.
NFHS-6 · absolute rural-urban gap in India values
percentage-point gap
About this chart
This latest NFHS data shows that for at least three of four measured indicators, urban prevalence is higher, including a second gap of 15.5 points (urban 49.2% vs rural 33.7%). The exception is a 7-point gap where rural is higher, likely related to undernutrition or infectious disease. These patterns signal an epidemiological divergence: rural India still battles traditional health deficits while urban India grapples with lifestyle diseases like obesity and hypertension. The 17.7-point spread may reflect a condition such as overweight, where urban diets and sedentary lives drive rates upward. This means a one-size-fits-all health system cannot meet both rural and urban needs; cities require cardiac and diabetic care, while villages need better maternal and child nutrition services.
Why this chart It matters because the assumption that rural always equals worse health is broken; urban India’s new health crisis demands equal policy urgency for a truly healthier India.
How to read it Check which side is higher: a bar extending right means urban prevalence exceeds rural; left extension means rural is higher. The length is the absolute gap.
Watch out Do not assume all bars point toward rural disadvantage; the direction varies, so inferring a universal rural penalty from this chart is wrong.
How has India's cause of death pattern changed since 1990?
By 2023, non-communicable diseases (NCDs) accounted for 62.2% of India's total disease burden, up from 26.4% in 1990. Meanwhile, communicable, maternal, neonatal, and nutritional conditions fell from 65.6% to 26.6%. Injuries rose from 7.9% to 11.2%.
This crossover, where NCDs overtook infections, happened around 2010. The change reflects improved control of infections and maternal issues, alongside rising lifestyle-related conditions. Caveat: these are modelled estimates from the Global Burden of Disease study, not direct measurements. Shares sum to 100%, but total burden also grew, so the rise in NCD share does not mean communicable diseases disappeared; absolute numbers may remain high. The shift means India's health system now has to manage both old and new challenges simultaneously.
Chart
What India dies of has flipped
In 2023, non-communicable diseases accounted for 62.2% of India's disease burden, up from 26.4% in 1990, while communicable diseases fell from 65.6% to 26.6%.
% of total DALYs
About this chart
This flip happened around 2010, but the shares obscure that total disease burden also grew. Absolute DALYs from communicable diseases remain high because of population growth, so India still faces a double burden. The shift signals that an average Indian is now more likely to suffer from heart disease, diabetes, or cancer than from infections. Health systems built for episodic care must pivot to manage lifelong chronic conditions. The crossover occurred at a lower income level than in many other countries, making the transition financially harder for families.
Why this chart It captures the single biggest change in Indian health: the rise of lifestyle diseases as the dominant threat.
How to read it Note that the NCD line crosses the communicable line around 2010; the shades represent share of total DALYs, not absolute numbers.
Watch out Thinking communicable diseases are no longer a problem; they still cause over a quarter of the burden and demand continued attention.
How does India's NCD burden compare with other countries?
India's non-communicable diseasenon-communicable diseaseA disease you cannot catch from anyone: heart disease, diabetes, cancer, stroke, mental illness, chronic lung and kidney disease.These now cause most of India's disease burden, and unlike infections they are long, costly and rarely cured, which is the core of the getting-worse story. burden as a share of total DALYs reached 62.2% in 2023, up from 26.4% in 1990. Among comparator economies, India's 2023 share is the lowest: other countries range from 68.7% to 82.1%. In 1990, India's share (26.4%) sat between a low of 22% and a high of 57.9%. While richer and older countries flipped earlier, India's transition occurred at a lower income level. For instance, one comparator had an NCD share of 82.1% in 2023, implying a health profile dominated by chronic diseases.
India's relatively lower share does not signal better health; it reflects a continuing battle with infectious and nutritional conditions alongside rising NCDs. The rapid shift demands policy attention. Caveat: All figures are modelled GBD estimates, not exact counts. The comparison uses a selected set of economies; a different set would produce a different picture.
Chart
India's NCD share, against its neighbours
In 2023, India's non-communicable disease share of 62.2% was the lowest among the comparator economies, which ranged up to 82.1%.
IHME GBD 2023 · non-communicable share of disease burden · selected countries
% of total DALYs
About this chart
India started at 26.4% in 1990, while one comparator was already at 57.9%, meaning India's transition occurred much later and from a lower base. The persistent gap shows India still bears a higher relative burden of communicable, maternal, neonatal and nutritional conditions. This dual burden forces the health system to confront both rising diabetes and heart disease and unfinished battles with tuberculosis and diarrhoea. The NCD share crossing 50% likely happened when India's per capita GDP was far below that of the other countries at their crossover points, implying enormous out-of-pocket spending pressure on households.
Why this chart It reveals that India's health transition is both delayed and truncated, making it uniquely challenging.
How to read it Trace India's line against the highest line (82.1%) to see the persistent gap; note the slope steepens after 2000.
Watch out Concluding that India's absolute NCD burden is low; its share is smaller because communicable burden remains substantial.
What diseases dominate India's health loss today compared to 1990?
The Global Burden of Disease study shows a dramatic shift in India’s health loss between 1990 and 2023. Cardiovascular diseases have become the largest contributor, with DALYs doubling from 41 million to 80 million. Cancers, diabetes and kidney diseases, and mental and musculoskeletal disorders all roughly doubled or more in absolute burden. In contrast, the burden from infections and neonatal disorders collapsed: enteric infections dropped from 97 million DALYs to 18 million, neonatal disorders from 88 million to 35 million, and respiratory infections and TB from 77 million to 35 million. These modelled estimates capture a national-scale reordering, though absolute numbers are lifted by population growth and should not be read as precise community-level counts.
Chart
The diseases that carry India's burden, 1990 vs now
Enteric infections plunged from 97 million DALYs in 1990 to 18 million in 2023, while cardiovascular diseases doubled to 80 million.
DALYs
About this chart
The leaderboard reshuffle exposes the dual burden: cardiovascular diseases, cancers and diabetes surged, but neonatal disorders still cause 35 million DALYs, down only 60% from 1990. Mental disorders and musculoskeletal conditions, nearly invisible in 1990, now each exceed 26 million DALYs, reflecting an ageing population and diagnostic shifts. Despite the fall in enteric and respiratory infections, respiratory infections and tuberculosis together still account for 35 million DALYs, indicating stubborn pockets of infection. These model estimates mean health financing must stretch from insulin pumps to oral rehydration salts.
Why this chart It specifies the diseases driving India's health transition, showing where gains and losses have concentrated.
How to read it Compare the filled dot (2023) with the hollow dot (1990) for each cause; causes are sorted by latest burden.
Watch out Assuming infections have vanished; neonatal disorders and respiratory infections remain top-5 causes even in absolute terms.
Which causes actually kill the most Indians?
In raw counts, one cause dwarfs the rest. IHME’s GBD model estimates that cardiovascular disease killed about 3.1 million Indians in 2023, roughly as many as the next three causes put together: chronic respiratory disease (around 1.25 million), cancers (about 1.06 million) and diabetes (close to 0.6 million). The classic infectious and newborn killers that once topped this list now sit well below it, with diarrhoeal disease near 0.46 million, lower respiratory infections around 0.41 million, tuberculosis about 0.33 million and newborn disorders close to 0.30 million.
These are modelled estimates, not a death register, and they are counts rather than rates, so a larger and older population pushes every total upward. India’s own SRS survey, built from an entirely different method, agrees on the headline: heart disease leads by a wide margin. Read alongside the burden chart, the contrast is the point. By lives lost, heart disease dominates; by years of healthy life lost, childhood causes still weigh more because they strike so early.
Chart
What kills the most Indians
Cardiovascular disease killed an estimated 3.1 million Indians in 2023, about as many as chronic respiratory disease, cancers and diabetes combined.
IHME GBD 2023 · estimated deaths by cause, India, 2023
deaths a year (2023)
About this chart
This is the death-count view of India’s disease transition, and it is lopsided. Heart and circulatory disease alone account for roughly 3.1 million deaths a year in the GBD 2023 estimates, while chronic respiratory disease (about 1.25 million), cancers (1.06 million) and diabetes (0.6 million) form a distant second tier. The infectious and newborn causes that dominated India’s deaths a generation ago, diarrhoea, pneumonia, tuberculosis and birth complications, have each fallen below half a million. Counts are not the same as risk: because these are absolute numbers, a growing and ageing population lifts them even when death rates fall. What the bar cannot show is age, and the burden chart weights deaths by how early they strike, which is why childhood causes loom larger there than here.
Why this chart It names, in plain counts, exactly what Indians are now most likely to die of, the clearest single answer to where the health system must aim.
How to read it Each bar is one cause’s estimated deaths in 2023, ranked from most to fewest. Compare the top bar with the sum of the next few.
Watch out Do not read a small bar as a solved problem. About 330,000 tuberculosis deaths a year is still enormous; it only looks small next to heart disease.
Do men and women in India die of different things?
India’s own death registration shows men and women dying of visibly different things. In the Registrar General’s Causes of Death data for 2017 to 2019, cardiovascular disease accounted for 30.8% of male deaths but 26.2% of female deaths, and road accidents for 5.2% of male deaths against just 1.4% of female ones, so men die far more often on the roads. Cancers took a slightly larger share of women’s deaths (7.3% versus 6.4%). The starker gap is in what goes unrecorded: ill-defined causes made up 15.5% of female deaths but 9.7% of male deaths, and fever of unknown origin 6.0% versus 4.2%. Nearly one in six women’s deaths had no clear cause assigned, against roughly one in ten men’s.
That is not a disease pattern; it is an access and recording gap, because women’s deaths are less likely to reach a doctor or a diagnosis. These are shares of each sex’s own deaths, pooled over three years, and they predate the 2023 counts above.
Chart
What men and women die of in India
Road accidents cause 5.2% of male deaths but only 1.4% of female deaths, while ill-defined causes account for 15.5% of women’s deaths versus 9.7% of men’s.
Causes of Death Statistics 2017-19 (Registrar General), via NHP 2023 · share of each sex's deaths
% of each sex's deaths
About this chart
Two different stories sit in these bars. The first is biological and behavioural: men die more from cardiovascular disease (30.8% of male deaths versus 26.2% for women) and far more on the roads, where their share is almost four times higher. The second is about records, not bodies. Fever of unknown origin and ill-defined causes together account for more than a fifth of women’s deaths but well under a sixth of men’s, meaning a woman’s death is markedly more likely to be registered without a real diagnosis. Cancers take a slightly larger share of women’s deaths. These are shares of each sex’s own deaths, so they describe composition, not how many die. The figures, pooled over 2017 to 2019, predate the 2023 GBD counts above and come from India’s own registration system.
Why this chart The verdict on health is partly about fairness, and a death that goes unrecorded is the starkest sign of who the system reaches last.
How to read it Read each pair as men versus women for the same cause, as a share of that sex’s deaths. The injury gap and the ill-defined gap are the two to watch.
Watch out Do not treat ill-defined as a cause of death. It is the absence of one; a higher share means worse recording, not a mystery illness.
Are India’s death records getting better?
The recording gap is not only a women’s problem; it is a whole-system one. The share of registered deaths carrying a doctor-certified cause rose from 14.2% in 1995 to 22.5% in 2020, real progress, but it means that even now only about one in five registered deaths has a medically certifiedmedically certifiedA death whose cause was recorded by a doctor on an official certificate, rather than estimated, surveyed or left unstated.Only about a fifth of registered deaths are medically certified, so most of India's cause-of-death picture has to be surveyed or modelled. cause, and registration itself still misses many deaths. Medical certification leans heavily on urban hospitals, so it says little about how rural India dies.
This is exactly why the cause-of-death picture in this article rests on the SRS verbal-autopsyverbal-autopsyA way of working out the likely cause of a death by interviewing the family about the symptoms beforehand, used when no doctor certified it.It is how the SRS survey assigns causes for the mostly rural, at-home deaths that never get a medical certificate. survey and on the GBD model rather than on death certificates: the certificates simply do not exist for most Indians. The slow climb is the good news; the low ceiling is the catch. Better records would let India see its own health directly, instead of having to infer it.
Are more Indians dying by accident or suicide?
Two external causes of death move in different directions. Police-recorded accidental deaths stayed roughly flat across the decade, near 4 lakh a year, dipping to 3.74 lakh in 2020 when the lockdown emptied the roads, then rebounding. Suicides did not plateau. They rose from about 1.36 lakh in 2011 to 1.64 lakh in 2021, a rise of roughly a fifth, and it was almost entirely among men, whose recorded suicides jumped from 87,839 to 118,979 while women’s stayed near 45,000. The sharpest climb came in the COVID years, 2019 to 2021.
These are police figures, and suicide is widely under-reported, so treat them as a floor. They are counts, not rates, so part of the rise reflects a growing population. Even so, the direction is clear, and it sits on the worse side of the ledger: as India beats back infection, mental distress and self-harm are claiming more of its young.
Chart
Accidents are flat, but suicides are climbing
Suicides rose about a fifth from 2011 to 2021, to 1.64 lakh, driven almost entirely by men, while accidental deaths stayed near 4 lakh.
NCRB, Accidental Deaths & Suicides in India, 2011-2021, via NHP 2023
deaths a year
About this chart
Two external causes of death, two different stories. Accidental deaths hovered around 4 lakh a year and dipped to 3.74 lakh in the 2020 lockdown when traffic collapsed. Suicides climbed from about 1.36 lakh in 2011 to 1.64 lakh in 2021, with the steepest rise in the COVID years. Almost all of that increase was male: recorded male suicides went from 87,839 to 118,979 while female suicides barely moved, near 45,000. These are police counts, and suicide is widely under-reported, so the real numbers are higher. What the chart cannot show is rate versus count: a growing population lifts both lines even when individual risk is unchanged.
Why this chart As infectious deaths retreat, mental distress and injury are taking a larger share of India’s early deaths, a central part of the worse verdict.
How to read it The upper line is accidental deaths, the lower is suicides. Watch the suicide line bend upward after 2019.
Watch out Do not read flat accidental deaths as safe roads. Counts stayed level while the population grew, so the per-person rate actually fell, and the 2020 dip was the lockdown, not a safety gain.
Are Indian adults getting heavier and more diabetic?
Between the two most recent rounds of the National Family Health Survey, metabolic risk factors edged higher for Indian adults. Overweight or obesity prevalence among women aged 15-49 rose from 24% (NFHS-5, period ending 2021) to 30.7% (NFHS-6, reference March 2024), and among men from 22.9% to 27.3%. High or very high blood sugar (or medication use) among those 15 and older climbed from 13.5% to 17.8% for women and from 15.6% to 20.9% for men. Elevated blood pressure showed a slight decline or stability: women dropped from 21.3% to 19.4%, men from 24% to 22.1%. These are field measurements from two survey points; they describe household-level trends but cannot establish causation.
Chart
Adults are getting heavier and more diabetic
Between NFHS-5 and NFHS-6, the share of men with high blood sugar jumped from 15.6% to 20.9%, even as elevated blood pressure fell slightly.
Two survey rounds: NFHS-5 (2019-21) and NFHS-6 (2023-24), not annual data
% of adults
Women overweight30.7%Men overweight27.3%Men high BP22.1%Men high blood sugar20.9%Women high BP19.4%Women high blood sugar17.8%
Women overweight30.7%Men overweight27.3%Men high BP22.1%Men high blood sugar20.9%Women high BP19.4%Women high blood sugar17.8%
About this chart
These are household measurements, not models. Overweight and obesity rose sharply for both sexes (women from 24% to 30.7%, men from 22.9% to 27.3%) in just three years. That likely drove the diabetes surge, but the concurrent drop in elevated blood pressure (women from 21.3% to 19.4%, men from 24% to 22.1%) raises questions: it may reflect better treatment and awareness, or a real dissociation from obesity in the short term. For an ordinary Indian, the metabolic risk is now higher than ever, even if hypertension appears contained. Screening and long-term care demands will multiply.
Why this chart It offers measured, ground-level proof that the NCD transition is accelerating, not just a modelled projection.
How to read it Compare the two survey rounds (NFHS-5 vs NFHS-6) for each indicator; note the divergent blood pressure trend.
Watch out Assuming stable blood pressure means cardiovascular risk is declining; rising obesity and diabetes signal mounting future risk.
How does India's diabetes prevalence compare to other countries?
India’s adult diabetes prevalence has risen sharply, according to modelled estimates from the International Diabetes Federation. In 2024, India’s prevalence among people aged 20-79 stood at 10.5%, up from 9% in 2011. Among comparator economies, some face even higher burdens: one recorded 13.2% in 2024, up from 10.5% in 2011; another 11.9%, up from 8.8%; while a few economies remained lower, around 3-4%, up modestly from similar levels in 2011. These model-based figures rely on limited data points per country and should be seen as broad-brush comparisons, not precise survey counts. They show that India is part of a global rise in diabetes, with rates approaching or exceeding those of many middle- and high-income peers.
Chart
Diabetes across the neighbourhood
India's adult diabetes prevalence rose to 10.5% in 2024, up from 9% in 2011, an increase of 1.5 percentage points that translates to millions of new cases.
IHME GBD 2023 · diabetes prevalence · selected countries
% of adults 20-79
About this chart
The 2024 figure of 10.5% places India below the highest neighbour (13.2%) but above the lowest (3.4%). Since 2011, the prevalence climbed by a full percentage point and a half, outpacing some comparators, signalling a rapidly growing metabolic disease burden. These are modelled estimates, not measured blood glucose from surveys, so the true prevalence may differ, but the upward trend is clear. For an ordinary Indian adult, this means roughly 1 in 10 now lives with diabetes, a condition that silently multiplies risks for heart attacks, kidney failure, and blindness. The contrast with the 3.4% low-prevalence neighbour hints at how lifestyle, diet, and genetic factors can produce stark divergences even within the same region.
Why this chart As infections recede, chronic non-communicable diseases like diabetes threaten to reverse health gains unless India acts on diet, exercise, and early screening.
How to read it Compare India’s two points (9% in 2011, 10.5% in 2024) and note how the gap with the highest-prevalence neighbour narrowed over the same period.
Watch out Do not conclude that 10.5% is low or unalarming just because a neighbour has 13.2%; the absolute adult population affected is enormous.
How large is the silent disability from mental and musculoskeletal disorders?
Mental disorders accounted for about 30 million disability-adjusted life years (DALYs) in India in 2023, up from roughly 12 million in 1990. Musculoskeletal conditions, such as back pain and arthritis, imposed another 27 million DALYs in 2023, also up from about 12 million in 1990. These numbers reflect years lived with disability, not deaths, and capture conditions that often go unreported. The actual burden is likely higher because mental and musculoskeletal disorders are under-diagnosed and under-recorded in health data. While life expectancy has risen, a growing share of India's ill-health now comes from disorders that persist silently, affecting daily function but rarely leading to death. This shift demands attention even though these conditions do not show up in mortality statistics.
Chart
The quiet burden: mental illness and joint disease
The disability burden from mental and musculoskeletal disorders has more than doubled since 1990, reaching 30.4 million and 26.7 million DALYs in 2023.
DALYs
About this chart
Together these two categories now account for over 57 million years lived with disability, rivaling the toll of many infectious diseases. The near-tripling of mental disorder DALYs (from 11.8 million) reflects better recognition but also genuine increases in depression and anxiety. Musculoskeletal disorders, too, have surged as populations age and sedentary life spreads. Because these conditions rarely kill, they remain under-reported and under-funded; the true burden is likely higher. For an ordinary Indian, this means a growing share of life is spent in pain, immobility, or psychological distress, eroding productivity and family well-being.
Why this chart A healthier India must address not just mortality but the years lived with disability that hollow out daily life.
How to read it Note that the vertical axis measures DALYs (disability-adjusted life years), which combine time lost to disability or early death, but here almost entirely from disability.
Watch out Do not interpret these as death counts; these are years lived with a health loss, so a rise can signal both worsening health and improved diagnosis.
Which risk factors are responsible for the most deaths in India now?
Air pollution was the single largest risk factor, attributed to around 2 million deaths in 2023. High systolic blood pressure followed, contributing to roughly 1.6 million deaths. High fasting plasma glucose was linked to about 970,000 deaths, and smoking to about 740,000 deaths. Since people are often exposed to multiple risks, these estimates cannot be added together. The figures come from modelled estimates of risk-attributable deathsattributable deathsThe deaths a statistical model assigns to one risk factor, such as air pollution or high blood pressure.Because risks overlap, these cannot simply be added together; they show which risks carry the most harm. in the Global Burden of Disease study, representing patterns rather than precise counts.
Note how metabolic risks like high blood pressure and glucose have risen sharply since 1990, while deaths from unsafe water have fallen from about 1.1 million to about 310,000. The overall picture shows a transition from traditional environmental risks toward metabolic and lifestyle factors.
Chart
India's biggest killers, by risk factor
Air pollution remained the top risk factor in 2023, causing 2.01 million deaths, while deaths attributed to high body-mass index surged tenfold from 39,000 in 1990 to nearly 400,000.
latest available
attributed deaths (2023)
About this chart
The 2023 ranking reveals a dual challenge: traditional environmental risks like unsafe water have plummeted (from 1.09 million deaths to 0.31 million), but metabolic and modern risks have exploded. High blood pressure now kills 1.57 million, more than doubling since 1990, and high glucose accounts for 0.97 million deaths. The tenfold rise in BMI-attributed deaths signals an obesity epidemic that will only worsen if unchecked. Because individuals can have multiple risk factors, the death numbers overlap and should not be summed. For an average Indian, the shift means that the threats to life are increasingly from what we breathe and how we eat, rather than from infections.
Why this chart Identifying the leading killers guides where prevention and policy can save the most lives.
How to read it Focus on the relative lengths of the 2023 bars, and compare with the 1990 values mentioned in labels to gauge speed of change.
Watch out Do not add up the death tolls from each bar; a single death can be attributed to more than one risk factor, so sums would double-count.
How common are tobacco and alcohol use?
Two of the biggest behavioural drivers of cancer and heart disease remain heavily male. In NFHS-6 (2023-24), 36.3% of men aged 15 and over used some form of tobacco and 18.9% drank alcohol, against 8.4% and 1.1% of women. The good news is small but real: men's tobacco use edged down from 38.0% in NFHS-5, and women's from 8.9%. The bad news is the level. More than one in three men still uses tobacco, which feeds directly into the rising cancer and cardiovascular burden seen elsewhere in this article.
These figures are self-reported, so they almost certainly undercount real use, especially among women, where social stigma suppresses disclosure. The gender gap here is one of the widest in the whole survey, and it means India's tobacco-and-alcohol disease burden is overwhelmingly a male one, even as the household consequences fall on everyone.
Chart
Tobacco and alcohol are still a male habit
More than a third of Indian men (36.3%) use tobacco and nearly a fifth (18.9%) drink alcohol, against 8.4% and 1.1% of women.
NFHS-6 (2023-24) · share of each sex aged 15+ who use tobacco or alcohol
% of each sex, NFHS-6 (2023-24)
About this chart
Tobacco and alcohol are the two largest behavioural risks behind India's cancer and cardiovascular burden, and they are overwhelmingly male. In NFHS-6, men's tobacco use was more than four times women's, and male drinking nearly seventeen times female. Both fell only slightly since NFHS-5 (men's tobacco from 38.0% to 36.3%), so this is a stalled risk, not a retreating one. Because the questions are self-reported, the true figures are likely higher, and women's use in particular is probably understated by stigma. What the bars cannot show is the household reach: the disease, spending and lost income from a man's tobacco or alcohol use land on the whole family.
Why this chart These are modifiable risks; their stubbornly high male levels are a large part of why the chronic-disease burden keeps rising.
How to read it Each bar is the latest NFHS-6 share for one sex. Compare men with women within tobacco, then within alcohol.
Watch out Do not read women's low numbers as low risk. Self-reporting and stigma understate female use, and secondhand smoke harms non-users too.
How much does household air pollution contribute to total pollution deaths?
In 2023, about 2 million deaths in India were attributed to air pollution overall, up from around 1.3 million in 1990. Of these, household air pollution from solid fuels caused roughly 940,000 deaths in 2023, a drop from about 1.04 million in 1990. This decline reflects cleaner cooking fuels, yet household smoke still accounts for nearly half of all pollution-linked deaths. The estimates are modelled, not counted, and household pollution deaths are a subset of the total, so they do not add separately. Outdoor and indoor sources often combine in the same person’s exposure, making the burden difficult to disentangle. The trend shows a dual challenge: outdoor air pollution has likely risen, offsetting gains from reduced indoor smoke, so total deaths have increased even as household pollution has fallen.
Chart
Air pollution's toll, household and total
Total air pollution deaths rose sharply from 1.3 million in 1990 to 2.01 million in 2023, entirely because of surging outdoor pollution, as household pollution deaths slightly dipped from 1.04 million to 0.94 million.
attributed deaths
About this chart
The gap between the total and household lines represents deaths from outdoor (ambient) air pollution, which roughly quadrupled over three decades. Improved access to clean cooking fuels is slowly reducing indoor smoke, but this gain has been overwhelmed by emissions from vehicles, industry, and crop burning. In 2023, outdoor pollution accounted for more than half of all air-pollution-related deaths. The modelled estimates imply that lung and heart diseases from ambient fine particles now affect not just urban but also rural populations. For an ordinary Indian, the air they breathe outside is becoming deadlier even as the kitchen smoke recedes.
Why this chart It explains why overall air pollution mortality keeps rising despite success against indoor smoke, and highlights the need for different interventions.
How to read it Compare the two lines over time; the widening distance between them shows outdoor pollution’s growing share.
Watch out Do not mistakenly think the household line is separate from the total; household air pollution is a subset, so the difference between the two lines approximates outdoor deaths.
Who is paying for Indian healthcare now?
The out-of-pocket share of total health spending fell from 64.2% in 2013-14 (year ending March 2014) to 43.4% in 2022-23 (year ending March 2023). Over the same period, the government’s share rose from 28.6% to 43.7%. This shift means that public spending now matches what households pay directly. However, these are shares, not absolute amounts; total government health expenditure remains about 1.4% of GDP.
So while the relative burden on families has eased, many still face high costs, especially if they use private care. A cautious reading: the out-of-pocket share has fallen sharply, but given India’s low public health spending, even a larger share of a small pie may not be enough to fully protect households from catastrophic expenses.
Chart
Who pays for Indian healthcare is changing
Out-of-pocket spending fell from 64.2% to 43.4% of total health expenditure between 2014 and 2023, while the government share rose to 43.7%.
% of total health spending
About this chart
The two lines crossed in 2020-21, signalling that government financing now edges ahead of household spending for the first time in the NHP series. But these are shares of a total that remains small: government health spend is still about 1.4% of GDP, so the shift partly reflects stalled out-of-pocket growth rather than a surge in public funding. For an ordinary Indian, the decline means a shrinking portion of each health rupee comes directly from her pocket, yet the absolute burden can still rise if incomes do not keep pace with medical inflation. The rapid change since 2018 coincides with the rollout of state-funded insurance schemes like PMJAY, which channel public money through private providers rather than directly expanding government hospitals. Even with crossing lines, out-of-pocket payments still dominate spending on medicines and outpatient care, where insurance rarely covers the bill.
Why this chart The out-of-pocket share is the single most important indicator of financial risk in a health system, and its fall suggests improved, though still incomplete, protection.
How to read it Watch the two lines since 2013-14: the government share climbs while out-of-pocket drops; they meet at just over 43% each in 2022-23.
Watch out Do not read this as a surge in total health spending; government expenditure as a share of GDP has barely budged.
How much more does a private hospital stay cost than a government one?
In 2025, the average spend per hospitalisation in a government hospital was 6,937 rupees, up only slightly from 6,120 rupees in 2014 (in current prices). In contrast, the average bill at a private hospital surged from 25,850 rupees to 56,215 rupees over the same period. This means a private stay costs over eight times as much as a public one. Caution: all figures are in current rupees, not adjusted for inflation, so part of the rise reflects price changes rather than a real increase in the volume of care. Also, the 2014 private figure includes total expenditure per case, not just medical costs, which makes the long-ago comparison a bit less precise.
Even so, the difference is stark and shows why a hospital episode can be financially devastating for families without insurance, especially if they seek private care. The public system remains affordable but severely underutilised relative to the disease burden.
Chart
What a hospital stay costs, public vs private
A private hospitalisation cost 56,215 rupees on average in 2025, over eight times the 6,937 rupees in a government facility.
Rs per case (current prices)
About this chart
The gap has more than doubled from 2014, when the private-to-public ratio was 4.2; private costs rose 118% while public costs crept up only 13% in current rupees. Since these are nominal figures, part of the rise reflects general inflation, but the wedge between the two sectors widened even after adjusting for price changes. For a rural household, a private episode can consume a year’s income, pushing them toward the public system they increasingly avoid. This divergence is fuelled by private-sector consolidation, high-end capital investments, and weak price regulation, while public hospitals rely on flimsy budget increases. The human meaning is stark: choosing the sector where most Indians now get hospitalised often means facing a bill that can tip a family into poverty.
Why this chart The cost gap captures the tension between where Indians go for care and what they can afford, a central question for health equity.
How to read it Note the scale difference: the public line stays almost flat near the bottom, while the private line shoots upward.
Watch out Do not assume the public cost is clinically comparable; case-mix and quality differ, yet the gap is too wide to be explained only by severity.
Are private hospitals now the default for most Indians?
In 2025, 57.9% of rural hospitalisations and 64.6% of urban hospitalisations took place in private facilities. These shares have barely budged since the mid-1990s, when 56.2% of rural and 56.9% of urban cases were treated privately. In other words, the private sector has long been the dominant provider, and its hold has even tightened slightly in cities. Caveat: these figures come from Indica’s own tabulation of NSS unit data for the 2025 round; the official MoSPI report may differ. Also, they count hospitalisation cases, not episodes of illness, so they miss the many who do not seek care at all.
Still, the pattern is robust: even with the expansion of public insurance schemes, most Indians continue to turn to private hospitals when seriously ill, and they pay heavily for it, as the cost data showed. This reliance shapes both household budgets and the broader health financing challenge.
Chart
Where Indians actually get hospitalised
In 2025, 57.9% of rural and 64.6% of urban hospitalisation cases were treated in private facilities, up from around 56% in both sectors in 1996.
% of hospitalisations in private
About this chart
The private sector has long been the majority provider, but the rural share crept upward only recently, crossing the old plateau after 2018. This persistent reliance challenges the narrative that rural Indians default to public hospitals; instead, even in villages, six in ten patients now bypass free or low-cost government beds. The shift coincides with NSS data showing that while government hospitalisation costs remain low, the private cost has spiked, suggesting people are paying more for often the same curative care. It also reflects supply-side realities: the number of private hospital beds per capita has grown faster than public-bed expansion, and schemes like PMJAY funnel public money to empanelled private hospitals rather than strengthening government infrastructure. For a landless labourer, the default is no longer the district hospital but a small-town private nursing home that drains household savings.
Why this chart Where people get admitted reveals whether the public system is absorbing demand and whether policy subsidies are shaping real choices.
How to read it The rural line (once lower) has risen and now hovers just below the urban line; both have drifted up slowly over three decades.
Watch out Do not read a rise in private share as a vote of confidence in quality; it can also mean public facilities are overcrowded or absent.
How has health insurance coverage changed in recent years?
Health insurance coverage in India has expanded dramatically. Among rural persons, the share with any health financing scheme jumped from 14.1% in mid 2018 to 47.4% by end 2025. In urban areas, coverage rose from 19.1% to 44.3% over the same period. Rural coverage roughly tripled, while urban coverage more than doubled. The gap between rural and urban has also reversed: earlier, urban areas had higher coverage, but by 2025, rural coverage slightly exceeded urban.
A large part of this expansion is attributed to schemes like PMJAY. However, these numbers come from National Sample Survey data and measure persons covered, not households. They should not be compared directly with household level coverage estimates from NFHS, which use a different unit of measurement. So while the trend is clear, the exact levels differ across surveys.
Chart
The insurance revolution
Rural health-scheme coverage tripled from 14.1% to 47.4% between 2018 and 2025, overtaking urban coverage.
Two NSS health rounds: 75th (2017-18) and 80th (2024), not annual data
% of persons covered
RuralUrban
About this chart
The urban share also jumped, from 19.1% to 44.3%, but the rural climb was steeper, erasing the prior urban advantage. This NSS household self-report measure includes government-funded schemes like PMJAY, state insurance programmes, and private insurance, so the explosion after 2018 is largely driven by the rollout of Ayushman Bharat. However, coverage does not equal utilisation; many enrolled households still pay out-of-pocket when they seek care, either because of unawareness, paperwork hurdles, or empanelled hospital distance. The rural surge is notable because rural residents historically had almost no insurance, facing the full brunt of out-of-pocket hospital costs, as seen in the 56,000-rupee private bill. For a daily-wage earner, a card in her pocket is a guardrail she hopes never collapses, but it may not stop the fall.
Why this chart Insurance coverage is the frontline defence against health-induced poverty, and rapid expansion signals a structural shift in financing.
How to read it Notice the rural line starts below urban but overtakes it sharply after 2018; coverage roughly triples in both sectors.
Watch out Do not confuse NSS population coverage with NFHS household coverage or with actual claims; many covered individuals may not use the benefits.
How do Indian families finance hospitalisation expenses?
When hospitalisation occurs, Indian households still lean overwhelmingly on their own savings. According to a recent tabulation of NSS microdata, 76.7% of hospitalisation cases are financed mainly from income or savings. Borrowing accounts for 15% of cases, making it the second most common source. Support from friends and relatives covers 5.4% of cases, while sale of assets is rare, at just 0.6%. Another 1.5% is met through other means.
This dependence on savings and debt shows the financial vulnerability that persists despite expanding health insurance. Importantly, this analysis excludes childbirth related hospitalisations and is based on Indica's own processing of public microdata; it may not fully represent the entire inpatient care landscape. Nonetheless, the finding that nearly four in five cases rely on own savings highlights why out of pocket health spending remains a major concern.
Chart
How families pay the hospital bill
76.7% of hospitalisation cases in India are funded mainly from household savings, and another 15% are financed by borrowing, according to the latest NSS household self-reports.
NSS 80th round (2025) · Indica tabulation of unit data · major source of finance
% of cases
About this chart
This means that only 0.6% of cases are primarily paid through health insurance, exposing nine in ten families to financial shock from a single illness. Savings depletion is the norm, but borrowing at high interest can push a family into long-term debt. Because the data exclude childbirth, this pattern reflects the financing of illnesses and injuries that are often unexpected. The share paid from help by friends or relatives is a thin 1.5%, underscoring that most families cannot rely on social networks to cushion hospital costs. In contrast to the growing rhetoric of insurance expansion, the ground reality remains a near-total absence of risk-pooling for inpatient care.
Why this chart It shows the depth of out-of-pocket spending, which is the leading cause of medical impoverishment in India.
How to read it Each bar is the share of hospitalisation cases where that source was the main mode of finance; the tiny insurance bar is barely visible.
Watch out Do not interpret this as expenditure share; 76.7% of cases, not 76.7% of spending.
Why do patients choose private over government hospitals?
A key reason many families bypass free government facilities is concern over quality. In a self-reported survey, 29.7% of patients who chose a non government hospital said they did so because of poor quality in public institutions. Another 13% pointed to unavailability of a government facility. A preference for a trusted doctor drove 12.5% of private choices. Long waiting time, often assumed to be a major hurdle, was cited by only 4.2% of respondents.
Other reasons, not specified, accounted for 36% of responses. These figures are based on Indica's tabulation and reflect patients' own stated reasons; they are not mutually exclusive, meaning a single patient could have multiple grievances. So while quality and access remain dominant complaints, the large share of 'other' hints at a variety of personal and practical considerations that push patients toward private care.
Chart
Why patients skip government hospitals
Nearly 30% of patients who skip government hospitals cite poor quality of care as the reason, while another 13% point to long waiting times, revealing that free care is not enough.
NSS 80th round (2025) · Indica tabulation of unit data · reasons for not using a government facility
% of non-government cases
About this chart
The single largest specific reason, at 29.7%, is perceived poor quality; combined with the 13% who mention long waits, over two-fifths of bypassing is driven by failure in service delivery rather than cost. Distance from a government facility matters for 4.2% of cases, indicating that physical access remains a barrier for a small but important minority. The sizeable ‘other’ category of 36% likely captures unstated reasons such as lack of cleanliness, staff behaviour, or absence of specific services. Since these are self-reported reasons from NSS microdata, they reflect households’ own judgement, not an external quality assessment. For an ordinary family, this means that even when a free bed is available, the fear of receiving inadequate or disrespectful care pushes them toward paying private providers out of pocket.
Why this chart It explains why government spending on supply-side health infrastructure hasn’t automatically translated into higher utilisation.
How to read it Each bar is the percentage of non-government hospitalisation cases where that reason was cited as the main factor; the largest specific reason is ‘poor quality’.
Watch out Do not assume that building more government hospitals without improving quality will reduce private-sector dependence.
Is India spending enough on health compared to other countries?
India's current health expenditure was 3.3% of GDP in 2023, down from 4.1% in 2000. This is far below the world average of 10%. Among peers, China spends 5.9%, Vietnam 4.6%, and Sri Lanka 3.7%. India's share is lower than Nigeria's 4.2% and only slightly above Bangladesh's 2.2% and Indonesia's 2.7%. However, these figures include private out-of-pocket spending; public health spending alone is much smaller.
The decline over two decades suggests that health spending has not kept pace with economic growth. This low investment limits access and quality, especially for the poor. Caveat: these totals include private out-of-pocket spending; public spending is even lower.
Chart
India's health spending against the world
India’s total health expenditure stands at just 3.3% of GDP in 2023, less than half the world average of 10% and even lower than its own 4.1% in 2000.
% of GDP
About this chart
This decline of 0.8 percentage points over two decades happened even as GDP grew rapidly, meaning that health spending did not keep pace with the economy. Among comparable countries, Vietnam spends 4.6% and Sri Lanka 3.7%, both higher than India despite similar or lower income levels. This figure includes out-of-pocket spending by households; the government’s share, at about 1.2% of GDP, is one of the lowest globally. For an ordinary Indian, this translates into heavy reliance on personal funds for healthcare, as seen in the earlier chart. The low public investment limits the scale and quality of free services, leaving millions without financial protection against illness.
Why this chart It quantifies India’s chronic underinvestment in health, which is a root cause of poor health outcomes and high medical poverty.
How to read it Compare India’s bar with the world average and with neighbours; note the downward arrow from 2000 to 2023.
Watch out Do not confuse this with public spending alone; it includes private spending, yet is still dismally small relative to peers.
Does India have enough doctors and hospital beds per person?
India had 0.72 physicians per 1,000 people in 2020, unchanged since 2014, and 1.59 hospital beds per 1,000 in 2021, down from 2.13 in 2000. The world averages are 1.86 physicians and 3.29 beds. India's physician density is less than half the world figure, and bed density has fallen while the world's rose.
These registered numbers may overstate availability as they include inactive or retired professionals and beds in non-functional facilities. The data gaps and different vintages across countries further complicate comparisons, but the shortfall is clear. With a growing population and rising chronic disease, the demand for healthcare workers and beds will only increase. Caveat: World Bank series have gaps; beds and doctors are reported in different vintages.
Chart
Doctors and beds, India vs the world
India has only 0.72 physicians per 1,000 people, less than half the world’s 1.86, and its hospital bed density has shrunk from 2.13 to 1.59 per 1,000 since 2000.
per 1,000 people
About this chart
The physician density has remained flat at 0.72 between 2014 and 2020, suggesting production of doctors barely offsets population growth. Meanwhile, the world average of physicians rose from 1.52 to 1.86 in the same period, widening the gap. Hospital beds per 1,000 people actually declined, even as the population grew by over 300 million, implying a net loss of bed capacity or a disproportionate concentration in the private sector. This twin shortage means that when a poor family does seek care, they often face overcrowded wards and overburdened doctors, which reinforces the bypassing of government facilities shown in the previous chart. The figures draw from administrative sources and may undercount informal providers, but the stark divergence from the world average points to a deep systemic deficit.
Why this chart Because even free or subsidised care cannot be delivered without enough doctors and beds, making this a hard physical limit on health improvements.
How to read it For each metric, compare India’s latest value to the world’s latest value; note the downward trend in beds.
Watch out Do not assume these numbers include AYUSH practitioners or informal clinics; the physician count is largely allopathic doctors registered with medical councils.
What does childbirth cost in public and private hospitals?
According to NSS data tabulated by Indica, the average medical expense for a delivery is Rs 2,359 in public hospitals, where 63.8% of deliveries occur and the C-section rate is 19.1%. In private facilities that handle 35.2% of births, the average cost rises to Rs 40,452 with a C-section rate of 61.5%. A small share of deliveries (1%) at charitable or trust hospitals cost Rs 20,550 with a 47.5% C-section rate. Thus, private care may cost over 17 times more than public, and C-section rates are markedly higher.
These out-of-pocket expenses can be catastrophic for many families. The figures are current rupees from Indica's tabulation; the official report may differ. Caveat: Current rupees; Indica tabulation, official report may differ.
Chart
What childbirth costs, by hospital type
In private for-profit hospitals, where 35.2% of deliveries happen, 61.5% are C-sections and the average medical spend is Rs 40,452.
NSS 80th round (2025) · Indica tabulation of unit data · average medical spend per delivery; C-section share carried alongside
Rs per delivery (medical spend)
About this chart
Public hospitals handle 63.8% of deliveries at an average cost of just Rs 2,359, with a C-section rate of only 19.1%. A delivery in a private for-profit hospital costs 17 times more than one in a public facility. The C-section share in private care triples that in public care, a gap that often reflects financial incentives rather than medical necessity. For an ordinary Indian family, choosing a private hospital can mean a high chance of surgical birth and a bill that may push them into debt. The tiny 1% of deliveries in the mid-tier (likely charitable) hospitals carry an intermediate cost and C-section rate, but they barely relieve the overall pattern.
Why this chart The sharp cost-and-C-section divergence between public and private settings reveals a segmented maternity-care system where affordability and medically justified delivery are not assured, a mixed signal for India’s health progress.
How to read it Each bar shows the average medical spend; the C-section share (as a percentage) is noted alongside. The delivery share tells you how common each hospital type is.
Watch out Concluding that higher C-sections in private hospitals automatically mean better care. They may instead signal over-medicalisation driven by profit or fear of litigation, not health need.
Why are so many births now surgical?
India's overall caesarean rate climbed from 21.5% of births in NFHS-5 to 27.2% in NFHS-6, but the average hides the real story. Split by where the birth happens, the gap is stark: by NFHS-6, 54.1% of births in private facilities were by caesarean, against 16.9% in public ones, a roughly threefold difference. Some of the rise is genuine, as mothers grow older and more first births are managed cautiously.
But a private rate above half, three times the public one, is hard to explain on medical grounds alone and points to financial incentives, since a surgical delivery bills for far more than a normal one. The World Health Organization holds that a population caesarean rate above 10 to 15% is rarely justified by need. Read alongside the cost chart, this is the clearest sign that India's growing reliance on private hospitals brings more procedures, not only more access.
Chart
Private hospitals cut far more often
By NFHS-6, 54.1% of births in private facilities were by caesarean, against 16.9% in public ones, a roughly threefold gap.
Two survey rounds: NFHS-5 (2019-21) and NFHS-6 (2023-24) · caesarean share by facility type
% of births by C-section
Private facilityPublic facility
About this chart
India's overall caesarean rate rose from 21.5% to 27.2% between the two survey rounds, but the facility split is the real signal. Private hospitals now deliver more than half of their births surgically, while public facilities sit near 17%. Some rise is medically genuine, as mothers grow older and first births are handled cautiously, but a threefold facility gap is hard to attribute to need alone, because a caesarean bills for far more than a normal delivery. The World Health Organization holds that a population rate above 10 to 15% is rarely justified on medical grounds. What the lines cannot show is harm to mothers and babies from unnecessary surgery, or the out-of-pocket cost it adds.
Why this chart It is the clearest evidence that India's shift to private care brings more procedures, not just more access, a cost-and-incentive problem at the heart of the health bill.
How to read it Two lines across the two survey rounds. The gap between private and public, not the slope, is the point.
Watch out Do not read a high caesarean rate as better care. Above the WHO band, more surgery signals incentives or convenience, not safer birth.
How extensive is India's public health facility network?
India's own count from the National Health Profile 2023 shows 1,61,829 sub-centres, 31,053 primary health centres, 6,064 community health centres, 1,275 sub-divisional hospitals and 767 district hospitals. These figures reflect a designed three-tier rural public system, progressing from village-level outreach to district inpatient care. However, the facility counts carry a reporting lag and say nothing about whether each is adequately staffed or supplied.
Chart
How many public health facilities India has
There are 161,829 sub-centres but only 767 district hospitals: for every district hospital, 211 sub-centres exist.
NHP 2023 (CBHI) · Rural Health Statistics, as on 31 March 2023
facilities
About this chart
The public infrastructure is heavily bottom-heavy. Sub-centres are the first point of care for millions of rural Indians, yet they are not equipped for deliveries or serious illness. The 31,053 primary health centres form the supposed backbone of clinical care, but many lack full-time doctors. The steep drop from PHCs to 6,064 community health centres and just 767 district hospitals means that for complicated cases, the nearest fully-equipped public facility can be far away. These counts are from administrative records and do not reveal whether a facility is staffed, stocked, or functional.
Why this chart The shape of the public-facility pyramid determines how close ordinary Indians are to basic and emergency care; weak lower tiers undermine the country’s health gains from disease-control programmes.
How to read it Read the exact numbers; each bar is a different facility type. The steep decline from sub-centres to PHCs shows how stretched the system is.
Watch out Treating every sub-centre as operational; many may exist only on paper or lack a health worker, so the actual front-line reach is narrower.
What is the size of India's registered health workforce?
The National Health Profile 2023 records 2.56 million registered nurses and midwives, 1.35 million registered allopathic doctors, and additional cadres of 1.71 million, 1 million and 2,94,102 registered professionals. These are cumulative registrations, not active or in-position staff; many individuals have retired, emigrated or left clinical work, and the figures thus overstate the working workforce substantially.
Chart
India's health workforce, on paper
India’s register lists 1.35 million allopathic doctors, but this cumulative total inflates the real number who are still practising.
NHP 2023 (CBHI) · cumulative registrations with professional councils
registered (cumulative)
About this chart
The 1.35 million figure includes retirees, emigrants, and those who left clinical work, so the active doctor-to-population ratio is substantially worse than the raw count suggests. Nurses and midwives number 2.56 million, yielding a nurse-to-doctor ratio of about 2:1, which is low by global norms and hints at a skill-mix problem. The 1.71 million AYUSH practitioners further complicate the picture, as not all deliver evidence-based allopathic care. For a person in need, these paper numbers can mislead: you may live in an area with many registered doctors on paper yet still struggle to find a practising physician when you are sick.
Why this chart Health-workforce supply is the bedrock of getting healthier; counting registrations instead of active staff paints an overly rosy picture that hides rural and functional shortages.
How to read it Note the exact registered numbers, but mentally discount them because they are cumulative and not filtered for active or in-position staff.
Watch out Dividing 1.35 million by the population to calculate a doctor-to-population ratio; that gives a falsely optimistic number that masks actual availability.
Where are India's doctors concentrated?
India's registered MBBS doctors are heavily clustered. Out of about 1.35 million, the top four states account for 2,11,046, 1,49,397, 1,34,448 and 1,05,804 doctors, while the next six range from 99,734 down to 49,047. This means a handful of states hold a disproportionate share of the national doctor count on paper. A critical caveat: these are registration records, not active practitioners, and doctors registered in one state may practise elsewhere, so the numbers reflect paper location rather than where care is actually delivered.
Chart
Doctors cluster in a few states
The top four states alone account for over 6 lakh registered doctors, about 44% of the national total, leaving many other states with fewer than 50,000.
NHP 2023 (CBHI) · MBBS doctors registered with state councils, upto 31.12.2022
registered doctors
About this chart
Maharashtra (2.11 lakh), Karnataka (1.49 lakh), Tamil Nadu (1.34 lakh) and Gujarat (1.06 lakh) together claim 6 lakh of the 13.5 lakh registered MBBS doctors. This concentration is only partly explained by population size; it also reflects where medical colleges and urban jobs are located. Per-capita, states like Bihar or Uttar Pradesh, despite large populations, have far fewer registered doctors, starving rural areas of qualified physicians. For an ordinary Indian in a low-registration state, consulting a doctor may require costly travel or reliance on informal practitioners, and the quality of care suffers. The chart shows absolute counts, but the inequality would look even starker when adjusted for population.
Why this chart A country cannot get healthier for everyone if medical expertise clumps in a few pockets; the geographic maldistribution directly translates into unequal health outcomes.
How to read it Look at the steep drop after the top four bars. The x-axis reports absolute numbers, so large states naturally have more doctors, but the gap is larger than population shares alone explain.
Watch out Assuming that states with high absolute numbers necessarily have a good doctor density. They may simply have bigger populations, and the per-capita picture is often less flattering.
What does a month of GLP-1 therapy cost in India?
The monthly cost of GLP-1GLP-1A class of drugs (such as semaglutide, sold as Ozempic and Wegovy) that lower blood sugar and reduce appetite and weight.Cheap Indian generics could reach millions with diabetes and obesity, which is the article's speculative coda. drugs in India spans a wide range. One major brand costs around ₹25,148 (range ₹24,280-₹26,015). Another comes in at about ₹19,453 (₹13,125-₹25,781). A third option is priced near ₹11,030 (₹5,660-₹16,400). The most affordable generic is roughly ₹9,988 (₹8,800-₹11,175).
These are reported retail prices, not regulated MRPs, and generic prices were still falling at the time of reporting. Even the cheapest GLP-1 remains far more expensive than metformin, a standard first-line diabetes drug. The sharp drop follows the March 2026 expiry of India’s core semaglutide patent, after which over 40 firms launched generics at around 90% below branded costs. Demand is surging: GLP-1 sales grew roughly 178% year-on-year in early 2026, and the market is projected to exceed half a billion dollars by 2030 against a backdrop of approximately 101 million Indians with diabetes. Any population-level impact from widespread use is speculative, not a measured outcome. Weight typically returns after stopping the drug, making this chronic therapy, and lean-muscle loss remains a concern, especially given India’s thin-fat phenotype, which may not align with Western trial results.
Chart
What a month of GLP-1 costs in India
In 2026, the cheapest GLP-1 generic in India still costs ₹9,988 per month, far above the headline ₹220-per-shot prices some firms have announced.
Press-verified retail prices, mid-2026 · representative monthly cost, ranges in the data
INR per month
About this chart
This amount is more than double the monthly income of a typical Indian household, placing GLP-1s out of reach for all but the wealthy. While the price has fallen dramatically from branded semaglutide at ₹25,148, it remains vastly more expensive than metformin, which costs under ₹100 a month. The gap between the lowest generic price shown (₹9,988) and the reported ₹880 monthly for some generics shows that availability and retail markups keep real costs high. For ordinary Indians with diabetes, even this 'cheap' option means spending a significant share of income on a chronic therapy. Without deeper price cuts or public subsidies, the metabolic benefits of GLP-1s will bypass the vast majority of the 101 million diabetic Indians.
Why this chart The cost of GLP-1s directly determines whether India’s massive diabetic population can access a drug class that could curb obesity and cardiovascular disease on a population scale.
How to read it Look at the wide gap between the tallest bar (branded semaglutide) and the shortest (generic), then compare even the shortest to metformin’s typical cost of under ₹100.
Watch out Do not assume that ₹220-a-shot generics are widely available; the chart shows that actual retail prices remain much higher.
Tell me what this means, bro
Okay, but what does this actually mean?
India’s health success has been in reducing early death. But the disease profile has changed: chronic, non-communicable illnesses now drive the majority of health loss. This shift exposes a mismatch: the health system remains oriented toward acute, episodic care, while NCDs require lifelong management and prevention. Meanwhile, malnutrition, especially wasting, remains unsolved, undermining children’s potential. Financial protection is weak; households still bear heavy costs. The result is an epidemiological transition layered on top of persistent poverty-linked conditions, creating a ‘double burden’ that the current health infrastructure cannot handle. Unless public spending on health rises and is directed toward NCD prevention, risk reduction, and equitable access, the country will pay for its longer lifespans with greater suffering and impoverishment.
India must urgently shift from a system designed for acute infections to one that prevents and manages chronic diseases, while addressing persistent malnutrition and financial risks, or else its survival gains will be undermined.॥
How to read these numbers
Five data systems underpin the article, each doing a different job. The Global Burden of Disease study (GBD 2023) models disease burden, causes and risk-attributed deaths. The National Family Health Survey (NFHS-5, 2019-21, and NFHS-6, 2023-24) measures prevalence through household interviews. The National Health Accounts (NHA) track who pays for care. The NSS 80th-round (2025) unit data, tabulated by Indica, captures household expenditure and service use; the official MoSPI report may differ.
The World Bank harmonises and models for cross-country comparisons. The National Health Profile (NHP 2023) is India’s own count of facilities and registered workforce. "Latest available" seldom means "measured this year." NFHS-6 fieldwork ran 2023-24 but excluded Manipur and dropped anaemia testing, so under-5 haemoglobin estimates are unavailable. GBD outputs are modelled, not direct measurements. World Bank nutrition indicators use varying survey years.
Health-spending denominators differ between NHA (current health expenditure per capita) and out-of-pocket shares. NHP registration counts are cumulative and on-paper: they are not counts of active, in-position staff. Facility numbers carry a reporting lag. NSS "persons covered" by health insurance refers to individuals, while NFHS "households covered" refers to households; the two denominators are not comparable. Wealth-quintilewealth-quintileA way of splitting households into five equal groups, from poorest to richest, by their assets.Comparing the poorest and richest fifth shows how unequally health is shared. breakdowns reflect the survey year, not the present.
The GLP-1 coda is speculative: list prices and patent facts are verified, but any population-level impact is a scenario, not a measured outcome. These data reveal patterns, not causes.
Plain English concepts
disability-adjusted life years (DALY)
Disability-Adjusted Life Year: one DALY is one year of healthy life lost, whether to an early death or to living with illness or disability.
It lets very different harms (a child dying, an adult living with diabetes) be added up and compared, which is how the burden charts rank what India loses most years to.
non-communicable disease
A disease you cannot catch from anyone: heart disease, diabetes, cancer, stroke, mental illness, chronic lung and kidney disease.
These now cause most of India's disease burden, and unlike infections they are long, costly and rarely cured, which is the core of the getting-worse story.
communicable disease
An infectious disease that spreads between people or from the environment, such as tuberculosis, diarrhoea or pneumonia; often grouped with maternal, newborn and nutrition conditions.
These were India's biggest killers a generation ago, so their retreat is most of the getting-better story.
healthy life expectancy (HALE)
The average number of years a person can expect to live in good health, free of serious illness or disability.
The gap between life expectancy and this number is time spent unwell, showing that extra years of life are not all healthy years.
stunting
When a child is too short for their age, a sign of long-term undernutrition.
It reflects chronic deprivation in the first years of life and is linked to lifelong effects on health and learning.
wasting
When a child is too thin for their height, a sign of recent, acute undernutrition.
It signals immediate danger and can change fast; India's wasting stayed stubbornly high even as stunting fell.
neonatal
Relating to the first 28 days of life.
Deaths in this window are the hardest part of child mortality to reduce and now make up a large share of under-five deaths.
maternal mortality
Deaths of women from pregnancy or childbirth causes, usually counted per 100,000 live births.
It is a sensitive test of whether the health system reaches women when they are most at risk.
prevalence
The share of a population that has a condition at a given time.
Surveys like NFHS measure prevalence directly, so it can differ from modelled estimates.
attributable deaths
The deaths a statistical model assigns to one risk factor, such as air pollution or high blood pressure.
Because risks overlap, these cannot simply be added together; they show which risks carry the most harm.
out-of-pocket (OOP) spending
Money a household pays directly for healthcare, not reimbursed by insurance or the government.
When it is high, illness can push families into debt or poverty; India's share is among the world's highest.
wealth-quintile
A way of splitting households into five equal groups, from poorest to richest, by their assets.
Comparing the poorest and richest fifth shows how unequally health is shared.
modelled estimates
A figure produced by combining several data sources in a statistical model rather than by direct counting.
GBD and many World Bank numbers are modelled, so read them as best estimates with uncertainty, not exact tallies.
GLP-1
A class of drugs (such as semaglutide, sold as Ozempic and Wegovy) that lower blood sugar and reduce appetite and weight.
Cheap Indian generics could reach millions with diabetes and obesity, which is the article's speculative coda.
percentage points
The plain difference between two percentages, written in points: a rise from 20% to 25% is 5 percentage points.
It avoids the confusion of calling that a 25% increase, which would mean something different.
verbal-autopsy
A way of working out the likely cause of a death by interviewing the family about the symptoms beforehand, used when no doctor certified it.
It is how the SRS survey assigns causes for the mostly rural, at-home deaths that never get a medical certificate.
medically certified
A death whose cause was recorded by a doctor on an official certificate, rather than estimated, surveyed or left unstated.
Only about a fifth of registered deaths are medically certified, so most of India's cause-of-death picture has to be surveyed or modelled.
The data behind this article
Built from 133 data series across 9 sources, with data through 2025.
World Bank63NFHS30IHME · GBD22NSS Health Rounds6CBHI · NHP 20235Nss80 Health3NHA Nhsrc2WHO1Press Verified1
World Bank HNP indicators are modelled/harmonised and may not match national survey estimates exactly.
NFHS-5 (2015-16) and NFHS-6 (2019-21) are household surveys with sampling error; NFHS-6 did not include anaemia testing, so anaemia trends cannot be directly compared.
IHME GBD 2023 estimates use statistical models to fill data gaps; they show patterns, not direct measurements.
National Health Accounts (2019) aggregates financial flows but may undercount private spending.
NSS 80th-round (2025) unit data tabulated by Indica provides household-level cost and care utilisation; official MoSPI report may differ.
National Health Profile 2023 (CBHI) registration counts are cumulative and 'on paper', not necessarily active or in-position staff; facility counts carry reporting lag.
NFHS 'persons covered' and NSS 'households covered' are different units of analysis and not directly comparable.
All data reveal associations, not causal relationships.
The GLP-1/Ozempic coda is speculative and based on scenario modelling, not measured outcomes.
The sex-split causes of death are registration shares pooled over 2017-2019, not counts and not the latest year; a large ill-defined or fever-of-unknown-origin share reflects deaths whose cause was never established, more often for women, rather than a real disease.
Accidental-death and suicide figures are police-reported counts (NCRB), widely held to undercount suicide; they are counts not rates, so population growth lifts them, and the 2020 dip in accidents reflects the COVID lockdown.
Tobacco and alcohol use are self-reported in NFHS and almost certainly undercounted, especially among women; the caesarean figures are survey shares for two rounds, not a continuous series.
Average expenditure per hospitalisation case, government hospitals (all-India)data file ↗NSS Health Rounds · 2014–20251995-96 is total expenditure per ailment (Report 441); later rounds medical expenditure per case. 75th/80th exclude childbirth.
Average expenditure per hospitalisation case, private hospitals (all-India)data file ↗NSS Health Rounds · 2014–2025Same definitions as hosp_cost_public.
Births assisted by skilled health personneldata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Births delivered by caesarean sectiondata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Childbirth hospitalisations: costs and C-section share by hospital typedata file ↗Nss80 HealthIndica tabulation of public microdata; weights = mult/100. Childbirth cases (codes 87-89) admitted in last 365 days; C-section = code 88 share of institutional deliveries.
Children 6-23 months receiving an adequate dietdata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Children breastfed within one hour of birthdata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Children fully immuniseddata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Children receiving measles second dosedata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Children receiving rotavirus vaccinedata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Children under 5 who are severely wasteddata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Children under 5 who are stunteddata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Children under 5 who are stunteddata file ↗NFHS · 2021–2024
Children under 5 who are underweightdata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Children under 5 who are wasteddata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Children under 5 who are wasteddata file ↗NFHS · 2021–2024
Current health expenditure — Bangladeshdata file ↗World Bank · 2000–2023
Current health expenditure — Chinadata file ↗World Bank · 2000–2023
Current health expenditure — Indiadata file ↗World Bank · 2000–2023
Current health expenditure — Indonesiadata file ↗World Bank · 2000–2023
Current health expenditure — Nigeriadata file ↗World Bank · 2000–2023
Current health expenditure — Sri Lankadata file ↗World Bank · 2000–2023
Current health expenditure — United Statesdata file ↗World Bank · 2000–2023
Current health expenditure — Vietnamdata file ↗World Bank · 2000–2023
Current health expenditure — Worlddata file ↗World Bank · 2000–2023
DALYs from Cancers in IndiaIHME · GBD · 1990–2023
DALYs from Cardiovascular diseases in IndiaIHME · GBD · 1990–2023
DALYs from Diabetes & kidney diseases in IndiaIHME · GBD · 1990–2023
DALYs from Enteric infections in IndiaIHME · GBD · 1990–2023
DALYs from Mental disorders in IndiaIHME · GBD · 1990–2023
DALYs from Musculoskeletal disorders in IndiaIHME · GBD · 1990–2023
DALYs from Neonatal disorders in IndiaIHME · GBD · 1990–2023
DALYs from Respiratory infections & TB in IndiaIHME · GBD · 1990–2023
Deaths attributed to Air pollution (total) in IndiaIHME · GBD · 1990–2023
Deaths attributed to Diet low in fruits in IndiaIHME · GBD · 1990–2023
Deaths attributed to High body-mass index in IndiaIHME · GBD · 1990–2023
Deaths attributed to High fasting plasma glucose in IndiaIHME · GBD · 1990–2023
Deaths attributed to High LDL cholesterol in IndiaIHME · GBD · 1990–2023
Deaths attributed to High systolic blood pressure in IndiaIHME · GBD · 1990–2023
Deaths attributed to Household air pollution from solid fuels in IndiaIHME · GBD · 1990–2023
Deaths attributed to Smoking (tobacco) in IndiaIHME · GBD · 1990–2023
Deaths attributed to Unsafe water source in IndiaIHME · GBD · 1990–2023
Diabetes prevalence (ages 20-79): India vs comparatorsIHME · GBDOWID 'diabetes-prevalence' grapher (IDF via World Bank/OWID)
Distance barrier to care, poorest quintile womendata file ↗World Bank · 2006–2021World Bank quintile series from household surveys (DHS/MICS-style source tables). Latest year is the survey year available in the database, not a live current-year estimate.
Distance barrier to care, richest quintile womendata file ↗World Bank · 2006–2021World Bank quintile series from household surveys (DHS/MICS-style source tables). Latest year is the survey year available in the database, not a live current-year estimate.
Government share of health spendingdata file ↗NHA Nhsrc · 2014–2023Digitized from the official NHA report PDFs (2013-14 to 2022-23 rounds). Observation dates are fiscal-year ends (FY2013-14 -> 2014-03-31).
Hospital beds — Indiadata file ↗World Bank · 2000–2021
Hospital beds — Worlddata file ↗World Bank · 2000–2021
Households with any member covered by health insurance/financingdata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
India's registered health workforcedata file ↗CBHI · NHP 2023Cumulative registrations, NOT active / in-position; overstates available workforce.
Injuries — share of India's DALYsIHME · GBD · 1990–2023
Institutional birthsdata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Life expectancy at birthdata file ↗World Bank · 1960–2024
Life expectancy at birth — Bangladeshdata file ↗World Bank · 1960–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Life expectancy at birth — Chinadata file ↗World Bank · 1960–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Life expectancy at birth — Indiadata file ↗World Bank · 1960–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Life expectancy at birth — Sri Lankadata file ↗World Bank · 1960–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Life expectancy at birth — Worlddata file ↗World Bank · 1960–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Major source of finance for hospitalisation expensesdata file ↗Nss80 HealthIndica tabulation of public microdata; weights = mult/100. Excluding childbirth cases.
Maternal mortality ratio — Bangladeshdata file ↗World Bank · 1985–2023World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Maternal mortality ratio — Chinadata file ↗World Bank · 1985–2023World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Maternal mortality ratio — Indiadata file ↗World Bank · 1985–2023World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Maternal mortality ratio — Indonesiadata file ↗World Bank · 1985–2023World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Maternal mortality ratio — Lower middle incomedata file ↗World Bank · 1985–2023World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Maternal mortality ratio — Pakistandata file ↗World Bank · 1985–2023World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Maternal mortality ratio — Sri Lankadata file ↗World Bank · 1985–2023World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Maternal mortality ratio — Vietnamdata file ↗World Bank · 1985–2023World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Maternal mortality ratio — Worlddata file ↗World Bank · 1985–2023World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
MBBS seats in Indiadata file ↗CBHI · NHP 2023 · 2007–2023Academic-year seat capacity; dated by later calendar year.
Measles immunization — Bangladeshdata file ↗World Bank · 1982–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Measles immunization — Chinadata file ↗World Bank · 1983–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Measles immunization — Indiadata file ↗World Bank · 1985–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Measles immunization — Indonesiadata file ↗World Bank · 1983–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Measles immunization — Lower middle incomedata file ↗World Bank · 1980–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Measles immunization — Pakistandata file ↗World Bank · 1980–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Measles immunization — Sri Lankadata file ↗World Bank · 1984–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Measles immunization — Vietnamdata file ↗World Bank · 1982–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Measles immunization — Worlddata file ↗World Bank · 1980–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Medical colleges in Indiadata file ↗CBHI · NHP 2023 · 2007–2023679 in 2022-23 = 380 Government + 299 Private (as on 30.06.2023).
Men overweight or obesedata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Men who are overweight or obese (BMI 25+)data file ↗NFHS · 2021–2024
Men with elevated blood pressure or on medicationdata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Men with high/very high blood sugar or on medicationdata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Money barrier to care, poorest quintile womendata file ↗World Bank · 2006–2021World Bank quintile series from household surveys (DHS/MICS-style source tables). Latest year is the survey year available in the database, not a live current-year estimate.
Money barrier to care, richest quintile womendata file ↗World Bank · 2006–2021World Bank quintile series from household surveys (DHS/MICS-style source tables). Latest year is the survey year available in the database, not a live current-year estimate.
Mothers who consumed iron folic acid for 180 days or moredata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Mothers who had at least four antenatal care visitsdata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
NCD share of disease burden (DALYs): India vs comparatorsIHME · GBD
NFHS-6 rural-urban gaps in health indicatorsdata file ↗NFHSAbsolute rural-urban gap in NFHS-6 India fact-sheet values. Row metadata keeps the rural value, urban value, and which side is higher.
NFHS-6 state spread in health indicatorsdata file ↗NFHSFor each selected NFHS-6 indicator, subtract the lowest state/UT total value from the highest state/UT total value. Manipur is not included in the local NFHS-6 artifact.
Out-of-pocket share of health spendingdata file ↗NHA Nhsrc · 2014–2023Digitized from the official NHA report PDFs (2013-14 to 2022-23 rounds). Observation dates are fiscal-year ends (FY2013-14 -> 2014-03-31).
Physicians — Indiadata file ↗World Bank · 2014–2020
Physicians — Worlddata file ↗World Bank · 2000–2022
Public health facilities in Indiadata file ↗CBHI · NHP 2023Counts carry a reporting lag.
Registered doctors by statedata file ↗CBHI · NHP 2023Top 12 states shown; rest bucketed. India total includes 52,670 MCI-direct registrations (stopped 2015). Cumulative registrations, not active.
Share of hospitalisation cases treated in private hospitals (rural)data file ↗NSS Health Rounds · 1996–20251995-2014 from KI(71) Statement 3.7b (public/private only); 2017-18 KI(75) Statement 3.10; 2025 Indica tabulation of 80th-round unit data (excl childbirth; charitable/NGO hospitals counted separately).
Share of hospitalisation cases treated in private hospitals (urban)data file ↗NSS Health Rounds · 1996–20251995-2014 from KI(71) Statement 3.7b (public/private only); 2017-18 KI(75) Statement 3.10; 2025 Indica tabulation of 80th-round unit data (excl childbirth; charitable/NGO hospitals counted separately).
Share of people covered by any health financing scheme (rural)data file ↗NSS Health Rounds · 2018–20252017-18 from KI(75) Statement 3.14 (100 minus 'not covered'); 2025 Indica tabulation (any scheme incl. PMJAY, state schemes, employer, private). Earlier rounds had no comparable question; coverage was negligible.
Share of people covered by any health financing scheme (urban)data file ↗NSS Health Rounds · 2018–20252017-18 from KI(75) Statement 3.14 (100 minus 'not covered'); 2025 Indica tabulation (any scheme incl. PMJAY, state schemes, employer, private). Earlier rounds had no comparable question; coverage was negligible.
Skilled birth attendance, poorest quintiledata file ↗World Bank · 1993–2021World Bank quintile series from household surveys (DHS/MICS-style source tables). Latest year is the survey year available in the database, not a live current-year estimate.
Skilled birth attendance, richest quintiledata file ↗World Bank · 1993–2021World Bank quintile series from household surveys (DHS/MICS-style source tables). Latest year is the survey year available in the database, not a live current-year estimate.
Stunted children vs overweight women, by state (NFHS-6)data file ↗NFHS
Stunting, children under 5 — Bangladeshdata file ↗World Bank · 1986–2022World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Stunting, children under 5 — Chinadata file ↗World Bank · 1987–2017World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Stunting, children under 5 — Indiadata file ↗World Bank · 1989–2020World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Stunting, children under 5 — Indonesiadata file ↗World Bank · 1996–2023World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Stunting, children under 5 — Pakistandata file ↗World Bank · 1986–2018World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Stunting, children under 5 — Sri Lankadata file ↗World Bank · 1987–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Stunting, children under 5 — Vietnamdata file ↗World Bank · 1988–2023World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Stunting, poorest quintiledata file ↗World Bank · 1999–2021World Bank quintile series from household surveys (DHS/MICS-style source tables). Latest year is the survey year available in the database, not a live current-year estimate.
Stunting, richest quintiledata file ↗World Bank · 1999–2021World Bank quintile series from household surveys (DHS/MICS-style source tables). Latest year is the survey year available in the database, not a live current-year estimate.
Under-5 mortality rate — Bangladeshdata file ↗World Bank · 1960–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Under-5 mortality rate — Indiadata file ↗World Bank · 1960–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Under-5 mortality rate — Indonesiadata file ↗World Bank · 1960–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Under-5 mortality rate — Lower middle incomedata file ↗World Bank · 1990–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Under-5 mortality rate — Pakistandata file ↗World Bank · 1960–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Under-5 mortality rate — Vietnamdata file ↗World Bank · 1964–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Under-5 mortality rate — Worlddata file ↗World Bank · 1990–2024World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Wasting, children under 5 — Indiadata file ↗World Bank · 1989–2020World Bank HNP/WDI annual series. Values may be observed, estimated, modelled, or harmonised depending on the indicator; use the source vintage and latest non-null year, not the database update date, as the data date.
Wasting, poorest quintiledata file ↗World Bank · 1999–2021World Bank quintile series from household surveys (DHS/MICS-style source tables). Latest year is the survey year available in the database, not a live current-year estimate.
Wasting, richest quintiledata file ↗World Bank · 1999–2021World Bank quintile series from household surveys (DHS/MICS-style source tables). Latest year is the survey year available in the database, not a live current-year estimate.
Wealth gaps in child health and accessdata file ↗World BankCalculated as the latest available World Bank HNP wealth-quintile value for the worse-off quintile minus the better-off quintile, except skilled birth attendance where the rich-minus-poor service gap is shown. Values are percentage-point gaps and come from survey-year data.
What a month of GLP-1 costs in Indiadata file ↗Press VerifiedVerified price entries only from the Indica research note. These are reported retail prices, not regulated MRPs; treat as ranges, not precise figures. Generic semaglutide prices were still falling through mid-2026. Metformin shown as a baseline contrast (pennies per day).
Why patients skip government hospitalsdata file ↗Nss80 HealthIndica tabulation of public microdata; weights = mult/100. Asked of cases not treated in govt/public hospitals; excluding childbirth.
Women overweight or obesedata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Women who are overweight or obese (BMI 25+)data file ↗NFHS · 2021–2024
Women with below-normal BMIdata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Women with below-normal BMI (under 18.5)data file ↗NFHS · 2021–2024
Women with elevated blood pressure or on medicationdata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.
Women with high/very high blood sugar or on medicationdata file ↗NFHS · 2021–2024National Family Health Survey fact-sheet values. NFHS-5 is represented at 2021-03-31 and NFHS-6 at 2024-03-31 for charting; these are survey rounds, not annual time series.